View Filing Data

Print Document View Excel Document

Document And Entity Information - USD ($)	12 Months Ended
Document And Entity Information - USD ($)	Dec. 31, 2019	Jul. 31, 2020	Jun. 30, 2020
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2019
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2019
Entity Registrant Name	ADDUS HOMECARE CORPORATION
Entity Central Index Key	0001468328
Trading Symbol	ADUS
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		15,664,952
Entity Public Float			$ 1,335,406,000
Entity Well-known Seasoned Issuer	No
Entity Current Reporting Status	No
Entity Voluntary Filers	No
Entity Interactive Data Current	No
Title of 12(b) Security	Common Stock, $0.001 par value
Security Exchange Name	NASDAQ
Entity File Number	001-34504
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	20-5340172
Entity Address, Address Line One	6303 Cowboys Way
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Frisco
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	75034
City Area Code	469
Local Phone Number	535-8200
Document Annual Report	true
Document Transition Report	false

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash	$ 111,714	$ 70,406
Accounts receivable, net of allowances	149,680	98,316
Prepaid expenses and other current assets	7,993	7,292
Total current assets	269,387	176,014
Property and equipment, net of accumulated depreciation and amortization	12,156	10,658
Other assets
Goodwill	275,368	135,442
Intangibles, net of accumulated amortization	57,079	23,784
Deferred tax assets, net	1,647	2,196
Operating lease assets, net	21,111
Total other assets	355,205	161,422
Total assets	636,748	348,094
Current liabilities
Accounts payable	19,641	12,238
Accrued payroll	30,587	22,449
Accrued expenses	22,429	11,586
Accrued workers’ compensation insurance	14,143	15,169
Current portion of long-term debt	728	62
Total current liabilities	87,528	61,504
Long-term liabilities
Long-term debt, less current portion, net of debt issuance costs	59,164	17,222
Long-term operating lease liabilities	14,301
Other long-term liabilities	163	877
Total long-term liabilities	73,628	18,099
Total liabilities	161,156	79,603
Stockholders’ equity
Common stock—$.001 par value; 40,000 authorized and 15,617 and 13,126 shares issued and outstanding as of December 31, 2019 and 2018, respectively	15	13
Additional paid-in capital	359,545	177,683
Retained earnings	116,032	90,795
Total stockholders’ equity	475,592	268,491
Total liabilities and stockholders’ equity	$ 636,748	$ 348,094

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2019	Dec. 31, 2018
Statement Of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	40,000,000	40,000,000
Common stock, shares issued	15,617,000	13,126,000
Common stock, shares outstanding	15,617,000	13,126,000

Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Income Statement [Abstract]
Net service revenues	$ 648,791	$ 516,647	$ 425,994
Cost of service revenues	469,553	379,843	310,119
Gross profit	179,238	136,804	115,875
General and administrative expenses	133,569	105,025	76,902
Loss (gain) on sale of assets	0	38	(2,467)
Depreciation and amortization	10,574	8,642	6,663
Provision for doubtful accounts	343	272	9,524
Total operating expenses	144,486	113,977	90,622
Operating income from continuing operations	34,752	22,827	25,253
Interest income	(1,523)	(2,592)	(66)
Interest expense	3,105	5,016	4,472
Total interest expense, net	1,582	2,424	4,406
Other income	0	0	217
Income from continuing operations before income taxes	33,170	20,403	21,064
Income tax expense	7,359	4,096	9,258
Net income from continuing operations	25,811	16,307	11,806
(Loss) earnings from discontinued operations	(574)	126	147
Net income	$ 25,237	$ 16,433	$ 11,953
Basic income per share
Continuing operations	$ 1.87	$ 1.35	$ 1.03
Discontinued operations	(0.04)	0.01	0.01
Basic income per share	1.83	1.36	1.04
Diluted income per share
Continuing operations	1.81	1.32	1.02
Discontinued operations	(0.04)	0.01	0.01
Diluted income per share	$ 1.77	$ 1.33	$ 1.03
Weighted average number of common shares and potential common shares outstanding:
Basic	13,816	12,049	11,470
Diluted	14,248	12,383	11,623

Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]
Balance at Dec. 31, 2016	$ 154,674	$ 12	$ 92,253	$ 62,409
Balance, shares at Dec. 31, 2016		11,527
Issuance of shares of common stock under restricted stock award agreements, shares		90
Forfeiture of shares of common stock under restricted stock award agreements, shares		(36)
Stock-based compensation	2,552		2,552
Shares issued for exercise of stock options	1,158		1,158
Shares issued for exercise of stock options, shares		51
Net income	11,953			11,953
Balance at Dec. 31, 2017	170,337	$ 12	95,963	74,362
Balance, shares at Dec. 31, 2017		11,632
Issuance of shares of common stock under restricted stock award agreements, shares		78
Forfeiture of shares of common stock under restricted stock award agreements, shares		(16)
Stock-based compensation	4,109		4,109
Shares issued for exercise of stock options	994		994
Shares issued for exercise of stock options, shares		42
Shares issued in secondary and public offering, net of offering costs	76,618	$ 1	76,617
Shares issued in secondary and public offering, net of offering costs, shares		1,390
Net income	16,433			16,433
Balance at Dec. 31, 2018	268,491	$ 13	177,683	90,795
Balance, shares at Dec. 31, 2018		13,126
Issuance of shares of common stock under restricted stock award agreements, shares		70
Forfeiture of shares of common stock under restricted stock award agreements, shares		(4)
Stock-based compensation	5,766		5,766
Shares issued for exercise of stock options	3,153		3,153
Shares issued for exercise of stock options, shares		125
Shares issued in secondary and public offering, net of offering costs	172,945	$ 2	172,943
Shares issued in secondary and public offering, net of offering costs, shares		2,300
Net income	25,237			25,237
Balance at Dec. 31, 2019	$ 475,592	$ 15	$ 359,545	$ 116,032
Balance, shares at Dec. 31, 2019		15,617

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net income	$ 25,237	$ 16,433	$ 11,953
Adjustments to reconcile net income to net cash provided by operating activities, net of acquisitions:
Depreciation and amortization	10,574	8,642	6,663
Non-cash restructuring			383
Deferred income taxes	(1,063)	(375)	2,470
Stock-based compensation	5,766	4,109	2,552
Amortization of debt issuance costs under the terminated credit facility			1,484
Amortization of debt issuance costs under the credit facility	716	606	382
Provision for doubtful accounts	343	272	9,524
Contingent consideration		(847)
Loss (gain) on sale of assets		38	(2,467)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(37,478)	(697)	19,412
Prepaid expenses and other current assets	(792)	1,652	(2,467)
Accounts payable	4,638	4,235	1,103
Accrued expenses and other liabilities	4,078	(865)	1,779
Net cash provided by operating activities	12,019	33,203	52,771
Cash flows from investing activities:
Proceeds from the sale of assets			3,702
Acquisitions of businesses, net of cash acquired	(184,076)	(62,440)	(24,354)
Purchases of property and equipment	(4,621)	(5,349)	(3,616)
Net cash used in investing activities	(188,697)	(67,789)	(24,268)
Cash flows from financing activities:
Proceeds from issuance of common stock, net of issuance costs	172,945	76,618
Borrowings on revolver — credit facility	23,458	20,000	30,000
Borrowings on revolver — terminated credit facility			20,000
Borrowings on term loan — credit facility	19,600	60,420	45,000
Payments on revolver — credit facility			(30,000)
Payments on revolver — terminated credit facility			(20,000)
Payments on term loan — credit facility	(735)	(104,858)	(563)
Payments on term loan — terminated credit facility			(24,063)
Payments on financing lease obligations	(63)	(1,013)	(1,432)
Payments for debt issuance costs under the credit facility	(372)	(923)	(2,862)
Cash received from exercise of stock options	3,153	994	1,158
Net cash provided by financing activities	217,986	51,238	17,238
Net change in cash	41,308	16,652	45,741
Cash, at beginning of period	70,406	53,754	8,013
Cash, at end of period	111,714	70,406	53,754
Supplemental disclosures of cash flow information:
Cash paid for interest	2,320	4,339	2,261
Cash paid for income taxes	7,303	4,097	6,725
Supplemental disclosures of non-cash investing and financing activities
Leasehold improvements acquired through tenant allowances	682
Tax benefit related to the amortization of tax goodwill in excess of book basis	$ 117	$ 117	$ 206

Significant Accounting Policies

12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Significant Accounting Policies

1. Significant Accounting Policies

Basis of Presentation and Description of Business

The Consolidated Financial Statements include the accounts of Addus HomeCare Corporation (“Holdings”) and its subsidiaries (together with Holdings, the “Company,” “we,” “us,” or “our”). The Company operates as a multi-state provider of three distinct but related business segments providing in-home services. In its personal care services segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy. The Company’s payor clients include federal, state and local governmental agencies, managed care organizations, commercial insurers and private individuals.

Principles of Consolidation

All intercompany balances and transactions have been eliminated in consolidation.

The Company used the cost method to account for its investments in joint ventures in which it owned 10% equity interests. The Company sold such investments on October 1, 2017, and received proceeds of approximately $1.3 million and recorded a pre-tax gain of $0.4 million.

Discontinued Operations

In 2013, the Company sold substantially all of the assets used in its then home health business (the “2013 Home Health Business”) in Arkansas, Nevada and South Carolina, and 90% of the 2013 Home Health Business in California and Illinois. Effective October 1, 2017, the Company sold its remaining 10% ownership interest in the 2013 Home Health Business in California and Illinois. The results of the 2013 Home Health Business are reflected as discontinued operations for all periods presented herein. For the year ended December 31, 2019, in connection with a 2013 Home Health Business litigation settlement, the Company recognized an expense of $0.6 million. The lawsuit was dismissed in full on October 15, 2019. See Note 13 to the Notes to Consolidated Financial Statements for additional information. For the years ended December 31, 2018 and 2017, discontinued operations consisted of the reduction of the indemnification reserve, net of tax, for the Company’s 2013 Home Health Business.

Reclassification of Prior Period Balances

Certain reclassifications have been made to prior period amounts to conform to the current-year presentation including the reporting of accrued payroll and accrued workers’ compensation insurance as separate line items on the Consolidated Balance Sheets. These reclassifications have no effect on the reported net income for the years ended December 31, 2019, 2018 and 2017. In addition, see Note 2 for a discussion of the impact of correcting immaterial errors in previously issued financial statements.

Revenue Recognition

Net service revenue is recognized at the amount that reflects the consideration the Company expects to receive in exchange for providing services directly to consumers. Receipts are from federal, state and local governmental agencies, managed care organizations, commercial insurers and private consumers for services rendered. The Company assesses the consumers' ability to pay at the time of their admission based on the Company's verification of the customer's insurance coverage under the Medicare, Medicaid, and other commercial or managed care insurance programs. Laws and regulations governing the governmental programs in which the Company participates are complex and subject to interpretation. Net service revenues related to uninsured accounts, or self-pay, is recorded net of implicit price concessions estimated based on historical collection experience to reduce revenue to the estimated amount the Company expects to collect. Amounts collected from all sources may be less than amounts billed due to implicit price concessions, resulting from client eligibility issues, insufficient or incomplete documentation, services at levels other than authorized, pricing differences and other reasons unrelated to credit risk. The Company monitors our net service revenues and collections from these sources and records any necessary adjustment to net service revenues based upon management’s assessment of historical write offs and expected net collections, business and economic conditions, trends in federal, state and private employer health care coverage and other collection indicators.

The initial estimate of net service revenues is determined by reducing the standard charge by any contractual adjustments, discounts, and implicit price concessions. Subsequent changes to the estimate of net service revenues are generally recorded in the period of the change. Changes in estimates of implicit price concessions, discounts, and contractual adjustments for performance obligations satisfied in prior years resulted in additional net service revenue of $0.1 million and a reduction in net service revenue of $1.5 million, for the years ended December 31, 2019 and 2018, respectively. Subsequent changes that are determined to be the result of an adverse change in the patient's ability to pay are recorded as bad debt expense.

Personal Care

The majority of the Company’s net service revenues are generated from providing personal care services directly to consumers under contracts with state, local and other governmental agencies, managed care organizations, commercial insurers and private consumers. Generally, these contracts, which are negotiated based on current contracting practices as appropriate for the payor, establish the terms of a customer relationship and set the broad range of terms for services to be performed at a stated rate. However, the contracts do not give rise to rights and obligations until an order is placed with the Company. When an order is placed, it creates the performance obligation to provide a defined quantity of service hours, or authorized hours, per consumer. The Company satisfies its performance obligations over time, given that consumers simultaneously receive and consume the benefits provided by the Company as the services are performed. As the Company has a right to consideration from customers commensurate with the value provided to customers from the performance completed over a given invoice period, the Company has elected to use the practical expedient for measuring progress toward satisfaction of performance obligations and recognizes patient service revenue in the amount to which the Company has a right to invoice.

Hospice Revenue

The Company generates net service revenues from providing hospice services to consumers who are terminally ill as well as related services for their families. Net service revenues are recognized as services are provided and costs for delivery of such services are incurred. The estimated payment rates are daily rates for each of the levels of care the Company delivers. Hospice companies are subject to two specific payment limit caps under the Medicare program each federal fiscal year, the inpatient cap and the aggregate cap. The inpatient cap limits the number of inpatient care days provided to no more than 20% of the total days of hospice care provided for the year. The aggregate cap limits the amount of Medicare reimbursement a hospice may receive, based on the number of Medicare patients served. For the year ended December 31, 2019, the Company acquired a liability of $0.4 million related to the Medicare inpatient cap limit. For the year ended December 31, 2018, the Company was below the payment limits and did not record a cap liability.

Home Health Revenue

The Company also generates net service revenues from providing home healthcare services directly to consumers mainly under contracts with Medicare and managed care organizations. Generally, these contracts, which are negotiated based on current contracting practices as appropriate for the payor, establish the terms of a relationship and set the broad range of terms for services to be performed on an episodic basis at a stated rate. Home health Medicare services were paid under the Medicare Home Health Prospective Payment System (“HHPPS”), for the year ended December 31, 2019 which is based on a 60-day episode of care as a unit of service. The HHPPS permits multiple, continuous episodes per patient. Medicare payment rates for episodes under HHPPS vary based on the severity of the patient’s condition as determined by assessment of a patient’s Home Health Resource Group score.

The Company elects to use the same 60-day length of episode that Medicare recognized as standard but accelerate revenue upon discharge to align with a patient’s episode length if less than the expected 60 days, which depicts the transfer of services and related benefits received by the patient over the term of the contract necessary to satisfy the obligations. The Company recognizes revenue based on the number of days elapsed during an episode of care within the reporting period. The Company satisfies its performance obligations as consumers receive and consume the benefits provided by the Company as the services are performed. As the Company has a right to consideration from Medicare commensurate with the services provided to customers from the performance completed over a given episodic period, the Company has elected to use the practical expedient for measuring progress toward satisfaction of performance obligations. Under this method recognizing revenue ratably over the episode based on beginning and ending dates is a reasonable proxy for the transfer of benefit of the service.

Accounts Receivable and Allowances

Accounts receivable is reduced to the amount expected to be collected in future periods for services rendered to customers prior to the balance sheet date. Management estimates the value of accounts receivable, net of allowances for implicit price concessions, based upon historical experience and other factors, including an aging of accounts receivable, evaluation of expected adjustments, past adjustments and collection experience in relation to amounts billed, current contract and reimbursement terms, shifts in payors and other relevant information. Collection of net service revenues the Company expects to receive is normally a function of providing complete and correct billing information to the payors within the various filing deadlines. The evaluation of these historical and other factors involves complex, subjective judgments impacting the determination of the implicit price concession assumption. In addition, the Company compares its cash collections to recorded net service revenues and evaluates its historical allowance for uncollectibles including implicit price concessions, based upon the ultimate resolution of the accounts receivable balance.

Prior to 2018, the Company established an allowance for doubtful accounts to the extent it was probable that a portion or all of a particular account will not be collected. The Company established its provision for doubtful accounts primarily by reviewing the creditworthiness of significant customers and through evaluations over the collectability of the receivables. An allowance for doubtful accounts was maintained at a level that the Company’s management believed was sufficient to cover potential losses.

With the modified retrospective adoption of ASU 2014-09, Revenue from Contracts with Customers, in 2018 and subsequent periods, subsequent adjustments that are determined to be the result of an adverse change in the payor’s ability to pay are recognized as provision for doubtful accounts. The majority of what historically was classified as provision for doubtful accounts under operating expenses is now treated as an implicit price concession factored into net service revenues. Our collection procedures include review of account aging and direct contact with our payors. We have historically not used collection agencies. An uncollectible amount is written off to the allowance account after reasonable collection efforts have been exhausted. As of December 31, 2019 and 2018, the allowance for doubtful accounts balance was $1.0 million and $0.9 million, respectively, which is included in the account receivable, net of allowances on the Company’s Consolidated Balance Sheets.

Property and Equipment

Property and equipment are recorded at cost and depreciated over the estimated useful lives of the related assets by use of the straight-line method. Maintenance and repairs are charged to expense as incurred. The estimated useful lives of the property and equipment are as follows:

Computer equipment		3—5 years
Furniture and equipment		5—7 years
Transportation equipment		5 years
Computer software		3—10 years
Leasehold improvements		Lesser of useful life or lease term

Goodwill and Intangible Assets

Under business combination accounting, assets and liabilities are generally recognized at their fair values and the difference between the consideration transferred, excluding transaction costs, and the fair values of the assets and liabilities is recognized as goodwill. The Company’s significant identifiable intangible assets consist of customer and referral relationships, trade names and trademarks and state licenses. The Company uses various valuation techniques to determine initial fair value of its intangible assets, including relief-from-royalty, income approach, discounted cash flow analysis, and multi-period excess earnings, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Under these valuation approaches, we are required to make estimates and assumptions about future market growth and trends, forecasted revenue and costs, expected periods over which the assets will be utilized, appropriate discount rates and other variables. The Company estimates the fair values of the trade names using the relief-from-royalty method, which requires assumptions such as the long-term growth rates of future revenues, the relief from royalty rate for such revenue, the tax rate and the discount rate. The Company estimates the fair value of existing indefinite-lived state licenses based on a blended approach of the replacement cost method and cost savings method, which involves estimating the total process costs and opportunity costs to obtain a license, by estimating future earnings before interest and taxes and applying an estimated discount rate, tax rate and time to obtain the license. The Company estimates the fair value of existing finite-lived state licenses based on a method of analyzing the definite revenue streams with the license and without the license, which involves estimating revenues and expenses, estimated time to build up to a current revenue base, which is market specific, and the non-licensed revenue allocation, revenue growth rates, discount rate and tax amortization benefits. The Company estimates the fair value of customer and referral relationships based on a multi-period excess earnings method, which involves identifying revenue

streams associated with the assets, estimating the attrition rates based upon historical financial data, expenses and cash flows associated with the assets, contributory asset charges, rates of return for specific assets, growth rates, discount rate and tax amortization benefits. The Company estimates the fair value of non-competition agreements based on a method of analyzing the factors to compete and factors not to compete, which involves estimating historical financial data, forecasted financial statements, growth rates, tax amortization benefit, discount rate, review of factors to compete and factors not to compete as well as an assessment of the probability of successful competition for each non-competition agreement.

The Company bases its fair value estimates on assumptions the Company believes to be reasonable but which are unpredictable and inherently uncertain. Actual future results may differ from those estimates.

The Company’s carrying value of goodwill is the excess of the purchase price over the fair value of the net assets acquired from various acquisitions. In accordance with ASC Topic 350, Goodwill and Other Intangible Assets, goodwill and intangible assets with indefinite useful lives are not amortized. The Company tests goodwill for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. The Company may use a qualitative test, known as “Step 0,” or a two-step quantitative method to determine whether impairment has occurred. In Step 0, the Company can elect to perform an optional qualitative analysis and based on the results skip the two-step analysis. Additionally, it is the Company’s policy to update the fair value calculation of our reporting units and perform the quantitative goodwill impairment test on a periodic basis. For the years ended December 31, 2019 and 2018, the Company performed the quantitative analysis to evaluate whether an impairment occurred. In 2017, the Company elected to implement Step 0 and were not required to conduct the remaining two-step analysis. Based on the totality of the information available, the Company concluded that it was more likely than not that the estimated fair values were greater than the carrying values of the reporting units, and as such, no further analysis was required. The Company concluded that there were no impairments for the years ended December 31, 2019, 2018 or 2017. As of December 31, 2019 and 2018, goodwill was $275.4 million and $135.4 million, respectively, included in the Company’s Consolidated Balance Sheets.

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names, trademarks, state licenses and non-competition agreements. Definite-lived intangible assets are amortized using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from three to twenty-five years, and assessed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years. The Company would recognize an impairment loss when the estimated future non-discounted cash flows associated with the intangible asset are less than the carrying value. An impairment charge would then be recorded for the excess of the carrying value over the fair value. The Company estimates the fair value of these intangible assets using the income approach. In accordance with ASC Topic 350, Goodwill and Other Intangible Assets, intangible assets with indefinite useful lives are not amortized. We test intangible assets with indefinite useful lives for impairment at the reporting unit level on an annual basis, as of October 1, or whenever potential impairment triggers occur, such as a significant change in business climate or regulatory changes that would indicate that an impairment may have occurred. No impairment charge was recorded for the years ended December 31, 2019, 2018 or 2017. As of December 31, 2019 and 2018, intangibles, net of accumulated amortization, was $57.1 million and $23.8 million, respectively, included in the Company’s Consolidated Balance Sheets. Amortization of intangible assets is reported in the statement of income caption, “Depreciation and amortization” and not included in the income statement caption cost of service revenues.

Debt Issuance Costs

The Company amortizes debt issuance costs on a straight-line method over the term of the related debt. This method approximates the effective interest method. In accordance with ASU 2015-03, Simplifying the Presentation of Debt Issuance Costs, the Company has classified the debt issuance costs as a direct deduction from the carrying amount of the related liability.

Workers’ Compensation Program

The Company’s workers’ compensation insurance program has a $0.4 million deductible component. The Company recognizes its obligations associated with this program in the period the claim is incurred. The cost of both the claims reported and claims incurred but not reported, up to the deductible, have been accrued based on historical claims experience, industry statistics and an actuarial analysis. The future claims payments related to the workers’ compensation program are secured by letters of credit. These letters of credit totaled $10.0 million and $10.8 million at December 31, 2019 and 2018, respectively. The Company monitors its claims quarterly and adjusts its reserves accordingly. These costs are recorded primarily as the cost of services on the Consolidated Statements of Income. As of December 31, 2019 and 2018, the Company recorded $14.1 million and $15.2 million, respectively, in accrued workers’ compensation insurance on the Company’s Consolidated Balance Sheets. As of December 31, 2019 and 2018, the

Company recorded $2.0 million and $1.7 million, respectively, in workers’ compensation insurance recovery receivables. The workers’ compensation insurance recovery receivable is included in prepaid expenses and other current assets on the Company’s Consolidated Balance Sheets.

Interest Income

Illinois law entitles designated service program providers to receive a prompt payment interest penalty based on qualifying services approved for payment that remain unpaid after a designated period of time. As the amount and timing of the receipt of these payments are not certain, the interest income is recognized when received and reported in the statement of income caption, “Interest income.” For the years ended December 31, 2019 and 2018, the Company received $0.7 million and $2.3 million, respectively, in prompt payment interest. For the year ended December 31, 2017, the Company did not receive any prompt payment interest. While the Company may be owed additional prompt payment interest in the future, the amount, timing and intent to provide receipt of such payments remains uncertain, and the Company will continue to recognize prompt payment interest income upon satisfaction of these constraints.

Interest Expense

Interest expense is reported in the Consolidated Statements of Income when incurred and consists of (i) interest and unused credit line fees on the credit facility, evidenced by the Credit Agreement (as defined in Note 9) and the credit facility evidenced by the 2017 Credit Agreement (as defined in Note 9), (ii) interest on our financing lease obligations and (iii) amortization and write-off of debt issuance costs.

Income Tax Expense

The Company accounts for income taxes under the provisions of ASC Topic 740, Income Taxes. The objective of accounting for income taxes is to recognize the amount of taxes payable or refundable for the current year and deferred tax assets and liabilities for the future tax consequences of events that have been recognized in its financial statements or tax returns. Deferred taxes, resulting from differences between the financial and tax basis of the Company’s assets and liabilities, are also adjusted for changes in tax rates and tax laws when changes are enacted. ASC Topic 740 also requires that deferred tax assets be reduced by a valuation allowance if it is more likely than not that some portion or all of the deferred tax assets will not be realized. ASC Topic 740 also prescribes a recognition threshold and measurement process for recording in the financial statements uncertain tax positions taken or expected to be taken in a tax return. In addition, ASC Topic 740 provides guidance on derecognition, classification, accounting in interim periods and disclosure requirements for uncertain tax positions. The Company recognizes interest and penalties accrued related to uncertain tax positions in interest expense and penalties within operating expenses on the Consolidated Statements of Income. Uncertain tax positions are immaterial for all periods presented.

Stock-based Compensation

The Company currently has one stock incentive plan, the 2017 Omnibus Incentive Plan (the “2017 Plan”), under which new grants of stock-based employee compensation are made. The Company accounts for stock-based compensation in accordance with ASC Topic 718, Stock Compensation. Compensation expense is recognized on a straight-line basis under the 2017 Plan over the vesting period of the equity awards based on the grant date fair value of the options and restricted stock awards. The Company utilizes the Black-Scholes Option Pricing Model to value the Company’s options. Forfeitures are recognized when they occur. Stock-based compensation expense was $5.8 million, $4.1 million and $2.5 million for the years ended December 31, 2019, 2018 and 2017, respectively.

Diluted Net Income Per Common Share

Diluted net income per common share, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The Company’s outstanding securities that may potentially dilute the common stock are stock options and restricted stock awards.

Included in the Company’s calculation of diluted earnings per share for the year ended December 31, 2019 were approximately 648,000 stock options outstanding, of which approximately 346,000 were dilutive. In addition, there were approximately 149,000 restricted stock awards outstanding, of which approximately 86,000 were dilutive for the year ended December 31, 2019.

Included in the Company’s calculation of diluted earnings per share for the year ended December 31, 2018 were approximately 683,000 stock options outstanding, of which approximately 247,000 were dilutive. In addition, there were approximately 149,000 restricted stock awards outstanding, of which approximately 88,000 were dilutive for the year ended December 31, 2018.

Included in the Company’s calculation of diluted earnings per share for the year ended December 31, 2017 were approximately 479,000 stock options outstanding, of which approximately 101,000 were dilutive. In addition, there were approximately 143,000 restricted stock awards outstanding, of which approximately 52,000 were dilutive for the year ended December 31, 2017.

Estimates

The financial statements are prepared by management in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) and include estimated amounts and certain disclosures based on assumptions about future events. The Company’s critical accounting estimates include the following areas: revenue recognition, allowance for doubtful accounts, goodwill and intangibles and business combinations and when required, the quantitative assessment of goodwill. Actual results could differ from those estimates.

Fair Value Measurements

The Company’s financial instruments consist of cash, accounts receivable, payables and debt. The carrying amounts reported on the Company’s Consolidated Balance Sheets for cash, accounts receivable, accounts payable and accrued expenses approximate fair value because of the short-term nature of these instruments. The carrying value of the Company’s long-term debt with variable interest rates approximates fair value based on instruments with similar terms using level 2 inputs as defined under ASC Topic 820, Fair Value Measurement.

The Company applies fair value techniques on a non-recurring basis associated with valuing potential impairment losses related to goodwill, if required, and indefinite-lived intangible assets and also when determining the fair value of contingent consideration, if applicable. To determine the fair value in these situations, the Company uses Level 3 inputs, under ASC Topic 820 and defined as unobservable inputs in which little or no market data exists; therefore requiring an entity to develop its own assumptions, such as discounted cash flows, or if available, what a market participant would pay on the measurement date.

The Company uses various valuation techniques to determine fair value of its intangible assets, including relief-from-royalty, income approach, discounted cash flow analysis, and multi-period excess earnings, which use significant unobservable inputs, or Level 3 inputs, as defined by the fair value hierarchy. Under these valuation approaches, we are required to make estimates and assumptions about future market growth and trends, forecasted revenue and costs, expected periods over which the assets will be utilized, appropriate discount rates and other variables.

Going Concern

In connection with the preparation of the financial statements for the years ended December 31, 2019 and 2018, the Company conducted an evaluation as to whether there were conditions and events, considered in the aggregate, which raised substantial doubt as to the entity’s ability to continue as a going concern within one year after the date of the issuance, or the date of availability, of the financial statements to be issued. The evaluation concluded that there did not appear to be evidence of substantial doubt of the entity’s ability to continue as a going concern.

Recently Adopted Accounting Pronouncements

In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-02, Leases (Topic 842). ASU 2016-02 requires lessees to recognize a lease liability and a right-of-use (“ROU”) asset for all leases, including operating leases, with a term greater than twelve months in their balance sheet. For income statement recognition purposes, leases will be classified as either a finance or an operating lease. In July 2018, the FASB issued ASU 2018-11, Leases (Topic 842) Targeted Improvements, which provided entities with an additional transition method. We elected to adopt the standard effective January 1, 2019 using the modified retrospective transition method. We elected the package of practical expedients available for expired or existing contracts, which allowed us to carryforward our historical assessments of (1) whether contracts are, or contain, leases, (2) lease classification and (3) initial direct costs. The most significant changes relate to the recognition of right-of-use assets and significant lease liabilities on our consolidated balance sheet as a result of our operating lease obligations, as well as the impact of new disclosure requirements. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

Recently Issued Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. ASU 2016-13 changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the financial asset to present the net carrying value at the amount expected to be collected on the financial asset. In addition, the Company is designing and implementing new processes and controls. ASU 2016-13 is effective as of January 1, 2020. Early adoption is permitted. We have reviewed our provision for doubtful accounts process as required by ASU 2016-13. Management estimates allowances on accounts receivable based upon historical experience and other factors, including an aging of accounts receivable, evaluation of expected adjustments, past adjustments and collection experience in relation to amounts billed, current contract and reimbursement terms, shifts in payors and other current relevant information. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

In January 2017, the FASB issued ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The new guidance eliminates the requirement to calculate the implied fair value of goodwill (i.e., Step 2 of the current goodwill impairment test) to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value (i.e., measure the charge based on the current Step 1). ASU 2017-04 is effective for annual and any interim impairment tests for periods beginning after December 15, 2019. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

In August 2018, the FASB issued ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract. ASU 2018-15 requires customers in a hosting arrangement that is a service contract to follow the internal-use software guidance in Accounting Standards Codification (“ASC”) 350-40 to determine which implementation costs to capitalize as assets or expense as incurred. The ASU is effective for annual periods, including interim periods within those annual periods, beginning after December 15, 2019. Early adoption is permitted. Adoption of the new standard did not have a significant impact on our results of operations or liquidity.

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. ASU 2019-12 intends to simplify various aspects related to accounting for income taxes and removes certain exceptions to the general guidance in ASC 740. In addition, the ASU clarifies and amends existing guidance to improve consistent application of its requirements. The ASU is effective for fiscal years, including interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted. Adoption of the new standard is not expected to have an impact on our results of operations or liquidity.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU 2020-04 provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, and other transactions subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. The ASU provides companies with optional guidance to ease the potential accounting burden associated with transitioning away from reference rates that are expected to be discontinued. Therefore, it will be in effect for a limited time through December 31, 2022. The ASU can be adopted no later than December 1, 2022 with early adoption permitted. The Company is evaluating the effect of adopting this new accounting guidance.

Revision of Previously Issued Financial Statements

12 Months Ended

Dec. 31, 2019

Accounting Changes And Error Corrections [Abstract]

Revision of Previously Issued Financial Statements

2. Revision of Previously Issued Financial Statements

In connection with management finalizing their financial reporting close process for the year ended December 31, 2019, management identified certain immaterial errors impacting the current period and previous periods dating back to periods prior to 2017, including interim periods within those years. Specifically, management determined there were certain errors in the information utilized to accurately estimate the implicit price concessions necessary to reduce net service revenues to the amount expected to be collected. Accordingly, management determined that our accounts receivable allowance was understated. The correction reflects the impact on the Company’s income tax provision and related accounts as a result of correcting for the error as discussed above. Additionally, the Company identified and corrected other immaterial unrelated income tax items impacting deferred tax assets and the reserve for uncertain tax positions. At December 31, 2018, the deferred tax liability, net of $0.5 million was reclassified to reflect the Company’s revised balance of a cumulative net deferred tax asset.

Management evaluated the impact of the errors on all previously issued financial statements and concluded such previously issued financial statements were not materially misstated; however, to reflect such corrections in the 2019 financial statements would materially misstate the current fiscal year. Accordingly, management revised previously issued financial statements to correct for the

impact of the errors. The Company’s consolidated financial statements have been revised from the amounts previously reported to correct these immaterial errors as shown in the tables below and are reflected throughout the financial statements and related notes, as applicable. We also corrected our financial statements for each of the interim periods in the years ended December 31, 2019 and 2018, see Note 17.

The Consolidated Balance Sheet has been revised to reflect the immaterial error for the year ended December 31, 2018.

Consolidated Balance Sheet as of December 31, 2018 (in thousands):

	As
	Previously					As
	Reported		Revision			Revised
Accounts receivable, net of allowances	$	108,000	$	(9,684	)	$	98,316
Prepaid expenses and other current assets		7,098		194			7,292
Deferred tax assets, net		—		2,196			2,196
Total assets		355,388		(7,294	)		348,094
Deferred tax liabilities, net		494		(494	)		—
Other long-term liabilities		635		242			877
Total liabilities		79,855		(252	)		79,603
Total stockholders’ equity		275,533		(7,042	)		268,491
Total liabilities and stockholders’ equity	$	355,388	$	(7,294	)		348,094

The cumulative effect of adjustments required to correct the errors in the financial statements for years prior to 2017 are reflected in the revised opening retained earnings balance as of January 1, 2017. The cumulative effect of those adjustments on all periods prior to 2017 decreased retained earnings as of January 1, 2017 by $4.2 million as reflected below.

Consolidated Statement of Stockholders’ Equity Opening Balance:

	Common Stock				Additional Paid in Capital		Retained Earnings			Total Stockholders' Equity
	Shares		Amount
Balance at January 1, 2017		11,527	$	12	$	92,253	$	66,653		$	158,918
Revision				—		—		(4,244	)		(4,244	)
Balance at January 1, 2017, as revised		11,527	$	12	$	92,253	$	62,409		$	154,674

The Consolidated Statements of Income has been revised to reflect the immaterial error for the years ended December 31, 2018 and December 31, 2017. With the adoption of ASU 2014-09, Revenue from Contracts with Customers, in 2018, the majority of what historically was classified as provision for doubtful accounts under operating expenses is treated as an implicit price concession factored into net service revenues. As a result of this adjustment, we recorded an additional $1.5 million for the year ended December 31, 2018, for a total of $11.0 million, as a reduction to revenue that would have been recorded as provision for doubtful accounts under the prior revenue recognition guidance.

Consolidated Statements of Income (in thousands):

	For the Years Ended December 31,
	2018							2017
	As							As
	Previously					As		Previously					As
	Reported		Revision			Revised		Reported		Revision			Revised
Net service revenues	$	518,119	$	(1,472	)	$	516,647	$	425,994	$	—		$	425,994
Gross profit		138,276		(1,472	)		136,804		115,875		—			115,875
Provision for doubtful accounts		272		—			272		8,409		1,115			9,524
Total operating expenses		113,977		—			113,977		89,507		1,115			90,622
Operating income from continuing operations		24,299		(1,472	)		22,827		26,368		(1,115	)		25,253
Income from continuing operations before income taxes		21,875		(1,472	)		20,403		22,179		(1,115	)		21,064
Income tax expense		4,498		(402	)		4,096		8,645		613			9,258
Net income from continuing operations		17,377		(1,070	)		16,307		13,534		(1,728	)		11,806
Net income	$	17,503	$	(1,070	)	$	16,433	$	13,681	$	(1,728	)	$	11,953

Basic income per share from continuing operations		1.44		(0.09	)		1.35		1.18		(0.15	)		1.03
Diluted income per share from continuing operations	$	1.40	$	(0.08	)	$	1.32	$	1.16	$	(0.14	)	$	1.02

Basic income per share		1.45		(0.09	)		1.36		1.19		(0.15	)		1.04
Diluted income per share	$	1.41	$	(0.08	)	$	1.33	$	1.17	$	(0.14	)	$	1.03

Additionally, the Consolidated Statement of Cash Flows has been revised to reflect the immaterial error for the years ended December 31, 2018 and December 31, 2017.

Consolidated Statements of Cash Flows (in thousands):

	For the Years Ended December 31,
	2018									2017
	As									As
	Previously						As			Previously						As
	Reported			Revision			Revised			Reported			Revision			Revised
Net income	$	17,503		$	(1,070	)	$	16,433		$	13,681		$	(1,728	)	$	11,953
Provision for doubtful accounts		272			—			272			8,409			1,115			9,524
Deferred income taxes		(43	)		(332	)		(375	)		1,754			716			2,470
Prepaid expenses and other current assets		1,964			(312	)		1,652			(2,364	)		(103	)		(2,467	)
Accrued expenses and other liabilities		(1,107	)		242			(865	)		1,779			—			1,779
Accounts receivable		(2,169	)		1,472			(697	)		19,412			—			19,412
Net cash provided by operating activities	$	33,203		$	—		$	33,203		$	52,771		$	—		$	52,771

Leases

12 Months Ended

Dec. 31, 2019

Leases [Abstract]

Leases

3. Leases

We have historically entered into operating leases for local branches, our corporate headquarters and certain equipment. The Company’s current leases have expiration dates through 2029. Certain of our arrangements have free rent periods and/or escalating rent payment provisions. We recognize rent expense on a straight-line basis over the lease term. Certain of the Company’s leases include termination options and renewal options for periods ranging from one to five years. Because we are not reasonably certain to exercise these renewal options, the options generally are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments.

When available, we use the rate implicit in the lease to discount lease payments to present value; however, most of our leases do not provide a readily determinable implicit rate. Therefore, we must estimate our incremental borrowing rate to discount the lease payments based on information available at lease commencement.

Amounts reported in the Consolidated Balance Sheets as of December 31, 2019 for our operating leases were as follows:

	December 31, 2019
	(Amounts in Thousands)
Operating lease assets, net	$	21,111

Short-term operating lease liabilities (in accrued expenses)		7,234
Long-term operating lease liabilities		14,301
Total operating lease liabilities	$	21,535

Lease Costs

Components of lease cost were reported in general and administrative expenses in the Consolidated Statements of Income as follows:

	For the Year Ended December 31, 2019
	(Amounts in Thousands)
Operating lease costs	$	7,219
Short-term lease costs		585
Total lease cost	$	7,804

Lease Term and Discount Rate

Weighted average remaining lease terms and discount rates for the year ended December 31, 2019 were as follows:

	2019
Operating leases:
Weighted average remaining lease term		3.42
Weighted average discount rate		5.14	%

Maturity of Lease Liabilities

A summary of our remaining operating lease payments as of December 31, 2019 were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in 12-month period ended December 31,
2020	$	7,975
2021		6,935
2022		4,331
2023		2,526
2024		1,437
Thereafter		389
Total future minimum rental commitments		23,593
Less: Imputed interest		(2,058	)
Total lease liabilities	$	21,535

The future minimum operating lease payments on non-cancelable leases as of December 31, 2018 under the accounting standards in effect as of that period were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in 12-month period ended December 31,
2019	$	6,374
2020		4,820
2021		3,460
2022		2,377
2023		2,130
Thereafter		1,382
Total future minimum rental commitments	$	20,543

Supplemental cash flow information

	For the Year Ended December 31, 2019
	(Amounts in Thousands)
Supplemental Cash Flows Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	7,574

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	10,299

Financing Leases

Some of our financing leases include provisions to purchase the asset at the conclusion of the lease. The adoption of ASC 842 did not impact the accounting for these leases. Financing leases were not material as of December 31, 2019 and 2018.

Public Offering

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Public Offering

4. Public Offering

On September 9, 2019, the Company completed a public offering of an aggregate 2,300,000 shares of common stock, par value $0.001 per share, including 300,000 shares of common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional shares at a public offering price of $79.50 per share (the “Public Offering”). The Company received net proceeds of approximately $172.9 million, after deducting underwriting discounts and estimated offering expenses of approximately $9.9 million. The Company used approximately $130.0 million from the net proceeds of the Public Offering to fund the purchase price for the Company’s acquisition of Hospice Partners of America, LLC (“Hospice Partners”), on October 1, 2019 and may use any remaining net proceeds of the Public Offering for general corporate purposes, including future acquisitions or investments, and the repayment of indebtedness outstanding under the Company’s credit facility. The Public Offering resulted in an increase to additional paid in capital of approximately $172.9 million on the Company’s Consolidated Balance Sheets at December 31, 2019.

On August 20, 2018, the Company together with Eos Capital Partners III, L.P. (the “Selling Stockholder”) completed a secondary public offering of an aggregate 2,100,000 shares of common stock, par value $0.001 per share at a purchase price per share to the public of $59.00 (the “2018 Public Offering Price”). Pursuant to the terms and conditions of the Underwriting Agreement, 1,075,267 shares of Common Stock were issued and sold by the Company (the “Primary Shares”) and 1,024,733 shares of Common Stock were sold by the Selling Stockholder (the “Secondary Shares”). The Company received net proceeds of approximately $59.1 million from the sale of 1,075,267 Primary Shares. On August 22, 2018, the underwriters exercised their full over-allotment option in connection with the offering and, as a result, the Company issued and sold an additional 315,000 shares of common stock to the underwriters at the 2018 Public Offering Price, less the underwriting discount. The over-allotment resulted in additional net proceeds to the Company of approximately $17.5 million. The Company used the net proceeds from the offering for general corporate purposes, and to pay down the $102.6 million of our delayed term loan in connection with the amendment and restatement of our credit facility. The Company did not receive any of the proceeds from the sale of the Secondary Shares. The secondary offering resulted in an increase to additional paid in capital of approximately $76.6 million, net of issuance costs of $5.4 million, on the Company’s Consolidated Balance Sheets at December 31, 2018.

Acquisitions

12 Months Ended

Dec. 31, 2019

Business Combinations [Abstract]

Acquisitions

5. Acquisitions

The Company’s acquisitions have been accounted for in accordance with ASC Topic 805, Business Combinations, and the resulting goodwill and other intangible assets were accounted for under ASC Topic 350, Goodwill and Other Intangible Assets. Under business combination accounting, the assets and liabilities are generally recognized at their fair values and the difference between the consideration transferred, excluding transaction costs, and the fair values of the assets and liabilities is recognized as goodwill. The results of each business acquisition are included on the Consolidated Statements of Income from the date of the acquisition.

Management’s assessment of qualitative factors affecting goodwill for each acquisition includes estimates of market share at the date of purchase, ability to grow in the market, synergy with existing Company operations and the payor profile in the markets.

Hospice Partners

On October 1, 2019, the Company completed the acquisition of the assets of Hospice Partners. The purchase price was approximately $135.6 million. The purchase of Hospice Partners was funded through a portion of the net proceeds of our Public Offering. With the purchase of Hospice Partners, we expanded our hospice operations through 21 locations in Idaho, Kansas, Missouri, Oregon, Texas and Virginia. The related acquisition costs were $1.6 million for the year ended December 31, 2019 and integration costs were $0.6 million for the year ended December 31, 2019. These costs were included in general and administrative expenses on the Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	112,484
Identifiable intangible assets		18,090
Cash		5,705
Property and equipment		164
Accounts receivable		6,506
Operating lease assets, net		2,518
Other assets		632
Accounts payable		(1,618	)
Accrued expenses		(4,650	)
Accrued payroll		(1,108	)
Deferred tax liability		(1,540	)
Long-term operating lease liabilities		(1,615	)
Total purchase price	$	135,568

Identifiable intangible assets acquired consist of $9.5 million in trade names with an estimated useful life of fifteen years, $2.5 million in non-competition agreements with estimated useful lives of three to five years and $6.1 million of indefinite lived state licenses. The preliminary estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Hospice Partners acquisition accounted for $14.8 million of net service revenues and $2.3 million of operating income for the year ended December 31, 2019.

Alliance Home Health Care

On August 1, 2019, the Company completed the acquisition of all of the assets of Alliance Home Health Care (“Alliance”). The purchase price was approximately $23.5 million. The purchase of Alliance was funded through the Company’s revolving credit facility and available cash. With the purchase of Alliance, the Company expanded its personal care, home health and hospice operations in the state of New Mexico. The related acquisition costs were $0.4 million for the year ended December 31, 2019 and integration costs were $0.4 million for the year ended December 31, 2019. These costs were included in general and administrative expenses on the Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	16,646
Identifiable intangible assets		5,422
Cash		260
Accounts receivable		1,665
Accounts payable		(299	)
Other liabilities		(236	)
Total purchase price	$	23,458

Identifiable intangible assets acquired consist of $1.1 million in state licenses, subject to amortization, with an estimated useful life of ten years and $4.3 million of indefinite lived state licenses. The preliminary estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Alliance acquisition accounted for $8.8 million of net service revenues and $2.1 million of operating income for the year ended December 31, 2019.

VIP Health Care Services

On June 1, 2019, the Company completed the acquisition of all of the assets of VIP Health Care Services (“VIP”). The purchase price was approximately $29.9 million. The purchase of VIP was funded through a combination of the Company’s delayed draw term loan portion of its credit facility and available cash. With the purchase of VIP, the Company expanded its personal care operations in the state of New York and into the New York City metropolitan area. The related acquisition costs were $0.3 million for the year ended December 31, 2019 and integration costs were $0.5 million for the year ended December 31, 2019. These costs were included in general and administrative expenses on the Consolidated Statements of Income and were expensed as incurred.

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	10,550
Identifiable intangible assets		15,370
Cash		110
Accounts receivable		6,058
Operating lease assets, net		2,278
Other assets		30
Property and equipment		27
Accounts payable		(462	)
Accrued expenses		(770	)
Accrued payroll		(1,742	)
Long-term operating lease liabilities		(1,531	)
Total purchase price	$	29,918

Identifiable intangible assets acquired consist of $10.7 million in state licenses, subject to amortization, and $4.7 million in customer relationships, with estimated useful lives of six and eight years, respectively. The preliminary estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The VIP acquisition accounted for $30.0 million of net service revenues for the year ended December 31, 2019, and $0.2 million of operating loss for the year ended December 31, 2019.

Ambercare Corporation

On May 1, 2018, the Company completed the acquisition of all the issued and outstanding securities of Ambercare Corporation (“Ambercare”). The purchase price was approximately $39.6 million, plus the amount of excess cash held by Ambercare at closing (approximately $12.0 million). The purchase of Ambercare was funded by a delayed draw term loan under the Company’s credit facility. With the purchase of Ambercare, the Company expanded its New Mexico personal care operations and entered into its hospice and home health segments in the state of New Mexico. The related acquisition costs were $0.8 million for the year ended December 31, 2018, and integration costs were $0.2 million and $1.6 million for the years ended December 31, 2019 and 2018, respectively. These costs were included in general and administrative expenses on the Company’s Consolidated Statements of Income, and were expensed as incurred. The results of Ambercare are included on the Company’s Consolidated Statements of Income from the date of the acquisition.

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	28,831
Cash		12,028
Identifiable intangible assets		9,944
Accounts receivable		6,512
Other assets		442
Property and equipment		154
Accrued expenses		(4,073	)
Deferred tax liability		(2,138	)
Financing lease		(75	)
Accounts payable		(3	)
Total purchase price	$	51,622

The Company acquired all of the outstanding stock of Ambercare. Identifiable intangible assets acquired consist of trade names and customer relationships, with estimated useful lives ranging from three to fifteen years, as well as indefinite lived state licenses. The estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are non-deductible for tax purposes.

The Ambercare acquisition accounted for $36.7 million of net service revenues and $7.1 million of operating income for the year ended December 31, 2018.

Arcadia Home Care & Staffing

On April 1, 2018, the Company acquired certain assets of Arcadia Home Care & Staffing (“Arcadia”), expanding its personal care services. The total consideration for the transaction was $18.9 million and was funded by a delayed draw term loan under the Company’s credit facility. The related acquisition costs were $0.8 million and $0.4 million for the years ended December 31, 2018 and 2017, and integration costs were $0.2 million and $1.1 million for the years ended December 31, 2019 and 2018, respectively. These costs were included in general and administrative expenses on the Company’s Consolidated Statements of Income, and were expensed as incurred.

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	13,072
Accounts receivable		5,317
Identifiable intangible assets		2,264
Property and equipment		155
Other assets		92
Accrued expenses		(1,540	)
Accounts payable		(508	)
Total purchase price	$	18,852

Identifiable intangible assets acquired consist of trade name, customer relationships and state licenses, with estimated useful lives ranging from seven to fifteen years. The estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Arcadia acquisition accounted for $32.7 million of net service revenues and $4.7 million of operating income for the year ended December 31, 2018.

In September 2018, the Company acquired certain assets of affiliate branches of Arcadia for $0.6 million using cash on hand, the Company recorded goodwill of $0.6 million on the Company’s Consolidated Balance Sheets. Goodwill generated from the acquisition is primarily attributable to expected synergies with existing Company operations and the goodwill acquired is deductible for tax purposes.

LifeStyle Options, Inc.

Effective January 1, 2018, the Company acquired certain assets of LifeStyle Options, Inc. (“LifeStyle”) in order to expand private pay services in Illinois. The total consideration for the transaction was $4.1 million, comprised of $3.3 million in cash and $0.8 million, representing the estimated fair value of contingent consideration, subject to the achievement of certain performance targets set forth in an earn-out agreement. As of December 31, 2018, the performance targets were not met and the contingent consideration was remeasured to zero.

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	2,751
Identifiable intangible assets		1,152
Accounts receivable		573
Other assets		32
Property and equipment		18
Accrued expenses		(291	)
Accounts payable		(105	)
Total purchase price	$	4,130

Identifiable intangible assets acquired consist of trade name and customer relationships, with estimated useful lives ranging from ten to fifteen years. The estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The LifeStyle acquisition accounted for $5.8 million of net service revenues and $0.5 million of operating income for the year ended December 31, 2018.

Sun Cities Home Care

Effective October 1, 2017, the Company acquired certain assets of Community Partnered Resources, Inc. d/b/a Sun Cities Caregivers and d/b/a Sun Cities Homecare (“Sun Cities”), in the state of Arizona, to enhance operations in an advantageous market. The total consideration for the transaction was comprised of $2.3 million in cash. The related acquisition costs were $0.1 million and $0.1 million for the years ended December 31, 2018 and 2017, respectively, were included in general and administrative expenses on the Company’s Consolidated Statements of Income, and were expensed as incurred.

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	1,089
Identifiable intangible assets		682
Accounts receivable		254
Cash		321
Other assets		10
Accrued expenses		(86	)
Accounts payable		(14	)
Total purchase price	$	2,256

Identifiable intangible assets acquired consist of trade name and customer relationships, with estimated useful lives ranging from seven to fifteen years. The estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Sun Cities acquisition accounted for $0.7 million of net service revenues and $0.1 million of operating income for the year ended December 31, 2017.

Options Home Care

On April 24, 2017, the Company entered into a definitive securities purchase agreement with HB Management Group, Inc. to purchase Options Services, Inc. d/b/a Options Home Care (“Options Home Care”). On August 1, 2017, the Company completed its acquisition of all the outstanding securities of Options Home Care for a total purchase price of $22.6 million. Options Home Care is a provider of personal care services in more than 20 counties in New Mexico and the acquisition expands the footprint of the Company’s existing operations in the state. The related acquisition costs were $0.1 million and $0.7 million for the years ended December 31, 2018 and 2017, respectively, and integration costs of $0.1 million for the year ended December 31, 2017, were included in general and administrative expenses on the Company’s Consolidated Statements of Income, and were expensed as incurred.

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	16,671
Identifiable intangible assets		5,324
Accounts receivable		1,084
Cash		205
Other assets		41
Accrued liabilities		(701	)
Total purchase price	$	22,624

Identifiable intangible assets acquired consist of trade name and customer relationships and the estimated useful lives of the respective assets, which range from three to ten years. The estimated fair value of identifiable intangible assets was determined, using Level 3 inputs as defined under ASC Topic 820, with the assistance of a valuation specialist. The fair value analysis and related valuations reflect the conclusions of management. All estimates, key assumptions, and forecasts were either provided by or reviewed by the Company. The goodwill and intangible assets acquired are deductible for tax purposes.

The Options Home Care acquisition accounted for $8.0 million of net service revenues and $1.5 million of operating income for the year ended December 31, 2017.

For the year ended December 31, 2019, the following table contains unaudited pro forma Consolidated Income Statement information of the Company as if each of the acquisitions of Hospice Partners, Alliance and VIP closed on January 1, 2018. For the year ended December 31, 2018, the following table contains unaudited pro forma Consolidated Income Statement information of the Company as if each of the acquisitions of Ambercare, Arcadia, LifeStyle, Sun Cities and Options closed on January 1, 2017. For the year ended December 31, 2017, the table contains unaudited pro forma Consolidated Income Statement information of the Company as if each of the acquisitions of Sun Cities and Options Home Care closed on January 1, 2016.

	For the Years Ended December 31, (Amounts in Thousands, Unaudited)
	2019		2018		2017
Net service revenues	$	726,727	$	550,326	$	441,858
Operating income from continuing operations		46,571		36,985		28,103
Net income from continuing operations		35,748		24,346		15,010
Net income per common share from continuing operations
Basic income per share	$	2.59	$	2.02	$	1.31
Diluted income per share	$	2.51	$	1.97	$	1.29

The pro forma disclosures in the table above include adjustments for amortization of intangible assets, tax expense and acquisition costs to reflect results that are more representative of the combined results of the transactions. This pro forma information is presented for illustrative purposes only and may not be indicative of the results of operations that would have actually occurred. In addition, future results may vary significantly from the results reflected in the pro forma information. The unaudited pro forma financial information does not reflect the impact of future events that may occur after the acquisition, such as anticipated cost savings from operating synergies.

Property and Equipment

12 Months Ended

Dec. 31, 2019

Property Plant And Equipment [Abstract]

Property and Equipment

6. Property and Equipment

Property and equipment consisted of the following:

	December 31,
	2019			2018
	(Amounts in Thousands)
Computer equipment	$	5,304		$	3,768
Furniture and equipment		3,410			3,161
Transportation equipment		157			156
Leasehold improvements		3,749			2,962
Computer software		9,563			6,712
		22,183			16,759
Less: accumulated depreciation and amortization		(10,027	)		(6,101	)
	$	12,156		$	10,658

Computer software includes $1.6 million and $1.3 million of internally developed software for the years ended December 31, 2019 and 2018, respectively. Depreciation and amortization expense totaled $4.0 million, $2.5 million and $2.0 million for the years ended December 31, 2019, 2018 and 2017, respectively.

For the year ended 2017, the Company completed its sale of substantially all of the assets used in three adult day services centers in Illinois. In connection with this sale, the Company received proceeds of approximately $2.4 million and recorded a pre-tax gain of $2.1 million reported in the Company’s Statement of Income caption, “Loss (gain) on sale of assets.”

Goodwill and Intangible Assets

12 Months Ended

Dec. 31, 2019

Goodwill And Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

7. Goodwill and Intangible Assets

The Company did not record any impairment charges for the years ended December 31, 2019, 2018 or 2017. The goodwill for the Company was $275.4 million and $135.4 million as of December 31, 2019 and 2018, respectively.

A summary of goodwill and related adjustments is provided below:

	Goodwill
	Personal Care			Hospice		Home Health		Total
	(Amounts In Thousands)
Goodwill at December 31, 2017	$	90,339		$	—	$	—	$	90,339
Additions for acquisitions		22,135			22,200		865		45,200
Adjustments to previously recorded goodwill		(97	)		—		—		(97	)
Goodwill at December 31, 2018		112,377			22,200		865		135,442
Additions for acquisitions		14,368			124,750		941		140,059
Adjustments to previously recorded goodwill		(168	)		33		2		(133	)
Goodwill at December 31, 2019	$	126,577		$	146,983	$	1,808	$	275,368

The Company recognized goodwill in the personal care segment of $10.6 million related to the acquisition of VIP on June 1, 2019. In connection with the acquisition of Alliance on August 1, 2019, the Company recognized goodwill in the personal care, hospice and home health segments of $3.4 million, $12.3 million and $0.9 million, respectively. Additionally, the Company recognized goodwill in the hospice segment of $112.5 million related to the acquisition of Hospice Partners on October 1, 2019, during the year ended December 31, 2019. Other immaterial acquisitions totaled $0.4 million of additional goodwill in the personal care segment. See Note 5 to the Notes to Consolidated Financial Statements for additional information regarding the acquisitions made by the Company for the years ended December 31, 2019 and 2018.

For the years ended December 31, 2019 and 2018, adjustments to the previously recorded goodwill are primarily adjustments to accounts receivable based on the final valuations.

The Company’s identifiable intangible assets consist of customer and referral relationships, trade names and trademarks, non-competition agreements and state licenses. Amortization is computed using straight-line and accelerated methods based upon the estimated useful lives of the respective assets, which range from three to twenty-five years. Customer and referral relationships are amortized systematically over the periods of expected economic benefit, which range from five to ten years. Goodwill and certain state licenses are not amortized pursuant to ASC Topic 350. The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following at December 31, 2019 and 2018:

	Customer and referral relationships			Trade names and trademarks			Non- competition agreements			State Licenses			Total
	(Amounts in Thousands)
Intangible assets with indefinite lives	$	—		$	—		$	—		$	13,306		$	13,306
Intangible assets subject to amortization:
Gross carrying amount		48,028			31,036			4,655			12,020			95,739
Accumulated amortization		(35,665	)		(12,941	)		(2,234	)		(1,126	)		(51,966	)
Intangible assets subject to amortization, net		12,363			18,095			2,421			10,894			43,773
Net balance at December 31, 2019	$	12,363		$	18,095		$	2,421		$	24,200		$	57,079

Intangible assets with indefinite lives	$	—		$	—		$	—		$	2,871		$	2,871
Intangible assets subject to amortization:
Gross carrying amount		42,356			21,551			2,155			241			66,303
Accumulated amortization		(32,752	)		(10,638	)		(1,981	)		(19	)		(45,390	)
Intangible assets subject to amortization, net		9,604			10,913			174			222			20,913
Net balance at December 31, 2018	$	9,604		$	10,913		$	174		$	3,093		$	23,784

During the year ended December 31, 2019, the Company acquired state licenses, subject to amortization, and customer relationships of $10.7 million and $4.7 million, respectively, related to the acquisition of VIP, indefinite lived state licenses of $4.3 million and $1.1 million of state licenses, subject to amortization, related to the acquisition of Alliance and trade names, indefinite lived state licenses and non-competition agreements of $9.5 million, $6.1 million and $2.5 million, respectively, related to the acquisition of Hospice Partners. Amortization expense related to the identifiable intangible assets amounted to $6.6 million, $6.2 million and $4.7 million for the years ended December 31, 2019, 2018 and 2017, respectively.

The weighted average remaining useful lives of identifiable intangible assets as of December 31, 2019 is 9.0 years.

The estimated future intangible amortization expense is as follows:

For the year ended December 31,	Total (Amount in Thousands)
2020	$	6,935
2021		6,440
2022		5,419
2023		4,936
2024		4,692
Thereafter		15,351
Total, intangible assets subject to amortization	$	43,773

Details of Certain Balance Sheet Accounts

12 Months Ended

Dec. 31, 2019

Details Of Certain Balance Sheet Accounts [Abstract]

Details of Certain Balance Sheet Accounts

8. Details of Certain Balance Sheet Accounts

Prepaid expenses and other current assets consist of the following:

	December 31,
	2019		2018
	(Amounts in Thousands)
Prepaid workers’ compensation and liability insurance	$	2,040	$	1,840
Workers’ compensation insurance receivable		1,989		1,692
Health insurance receivable		1,567		564
Other		2,397		3,196
Total prepaid expenses and other current assets	$	7,993	$	7,292

Accrued expenses consisted of the following:

	December 31,
	2019		2018
	(Amounts in Thousands)
Current portion of operating lease liabilities	$	7,234	$	—
Accrued health insurance		4,140		3,926
Accrued professional fees		2,517		2,260
Accrued payroll taxes		1,843		769
Other		6,695		4,631
Total accrued expenses	$	22,429	$	11,586

Long-Term Debt

12 Months Ended

Dec. 31, 2019

Long Term Debt [Abstract]

Long-Term Debt

9. Long-Term Debt

Long-term debt consisted of the following:

	December 31,
	2019			2018
	(Amounts in Thousands)
Revolving loan under the credit facility	$	43,458		$	20,000
Term loan under the credit facility		18,865			—
Financing leases		21			81
Less unamortized issuance costs		(2,452	)		(2,797	)
Total		59,892			17,284
Less current maturities		(728	)		(62	)
Long-term debt	$	59,164		$	17,222

Amended and Restated Senior Secured Credit Facility

On October 31, 2018, the Company entered into the Amended and Restated Credit Agreement, dated as of October 31, 2018, with certain lenders and Capital One, National Association, as a lender and as agent for all lenders (as amended by the Amendment (as hereinafter defined), the “Credit Agreement”), which amended and restated the Company’s existing credit agreement. This credit facility totaled $269.6 million, inclusive of a $250.0 million revolving loan and a $19.6 million delayed draw term loan, and is evidenced by the Credit Agreement. This credit facility amended and restated the Company’s existing senior secured credit facility totaling $250.0 million. As used throughout this Annual Report on Form 10-K, “credit facility” shall mean the credit facility evidenced by the Credit Agreement. The maturity of this credit facility is May 8, 2023. Interest on the Company’s credit facility may be payable at (x) the sum of (i) an applicable margin ranging from 0.75% to 1.50% based on the applicable senior net leverage ratio plus (ii) a base rate equal to the greatest of (a) the rate of interest last quoted by The Wall Street Journal as the “prime rate,” (b) the sum of the federal funds rate plus a margin of 0.50% and (c) the sum of the adjusted LIBOR that would be applicable to a loan with an interest period of one month advanced on the applicable day (not to be less than 0.00%) plus a margin of 1.00% or (y) the sum of (i) an applicable margin ranging from 1.75% to 2.50% based on the applicable senior net leverage ratio plus (ii) the offered rate per annum for similar dollar deposits for the applicable interest period that appears on Reuters Screen LIBOR01 Page (not to be less than zero). Swing loans may not be LIBOR loans. The availability of additional draws under this credit facility is conditioned, among other things, upon (after giving effect to such draws) the Total Net Leverage Ratio (as defined in the Credit Agreement) not exceeding 3.75:1.00. In certain circumstances, in connection with a Material Acquisition (as defined in the Credit Agreement), the Company can elect to increase its Total Net Leverage Ratio compliance covenant to 4.25:1.00 for the then current fiscal quarter and the three succeeding fiscal quarters. In connection with this credit facility, the Company incurred approximately $0.9 million of debt issuance costs.

Addus HealthCare, Inc. (“Addus HealthCare”) is the borrower, and its parent, Holdings, and substantially all of Holdings’ subsidiaries are guarantors under this credit facility, and it is collateralized by a first priority security interest in all of the Company’s and the other credit parties’ current and future tangible and intangible assets, including the shares of stock of the borrower and subsidiaries. The Credit Agreement contains affirmative and negative covenants customary for credit facilities of this type, including limitations on the Company with respect to liens, indebtedness, guaranties, investments, distributions, mergers and acquisitions and dispositions of assets.

The Company pays a fee ranging from 0.20% to 0.35% based on the applicable senior net leverage ratio times the unused portion of the revolving loan portion of the credit facility.

The Credit Agreement contains customary affirmative covenants regarding, among other things, the maintenance of records, compliance with laws, maintenance of permits, maintenance of insurance and property and payment of taxes. The Credit Agreement also contains certain customary financial covenants and negative covenants that, among other things, include a requirement to maintain a minimum Interest Coverage Ratio (as defined in the Credit Agreement), a requirement to stay below a maximum Total Net Leverage Ratio (as defined in the Credit Agreement) and a requirement to stay below a maximum permitted amount of capital expenditures, as well as restrictions on guarantees, indebtedness, liens, investments and loans, subject to customary carve outs, a restriction on dividends (provided that Addus HealthCare may make distributions to the Company in an amount that does not exceed $7.5 million in any year absent of an event of default, plus limited exceptions for tax and administrative distributions), a restriction on the ability to consummate acquisitions (without the consent of the lenders) under its credit facility subject to compliance with the Total

Net Leverage Ratio (as defined in the Credit Agreement thresholds), restrictions on mergers, dispositions of assets, and affiliate transactions, and restrictions on fundamental changes and lines of business. As of December 31, 2019, the Company was in compliance with its covenants under the Credit Agreement. However, the Company was unable to timely file this Annual Report on Form 10-K, which would have included its audited financial statements for the year ended December 31, 2019. The Company is required to deliver annual audited financial statements under the affirmative covenants of its Credit Agreement. The Company obtained consent from the Required Lenders (as defined in the Credit Agreement) to extend the timeline of the audited financials for the year ended December 31, 2019 to not later than October 31, 2020.

On September 12, 2019, the Company entered into a First Amendment (the “Amendment”) to its Credit Agreement. The Amendment increased the Company’s credit facility by $50.0 million in incremental revolving loans, for an aggregate $300.0 million in revolving loans. The Amendment provides that future incremental loans may be for term loans or an increase to the revolving loan commitments. The Amendment further provides that the proceeds of the incremental revolving loan commitments may be used for, among other things, general corporate purposes. In connection with the modification of this Amendment, the Company incurred approximately $0.4 million of debt issuance costs.

The Company drew approximately $23.5 million on the revolver portion of its credit facility to fund, in part, the purchase price for the Alliance acquisition on August 1, 2019. Additionally, the Company drew $19.6 million under the delayed draw term loan portion of its credit facility to fund, in part, the acquisition of VIP on June 1, 2019.

At December 31, 2019, the Company had a total of $43.4 million of revolving loans, with an interest rate of 3.44%, and $18.9 million of term loans, with an interest rate of 3.45%, outstanding on its credit facility. After giving effect to the amount drawn on its credit facility, approximately $10.0 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $191.4 million available for borrowing under its credit facility.

During the year ended December 31, 2018, the Company drew a total of approximately of $60.4 million of delayed draws terms under its credit facility to fund the acquisition of Ambercare and Arcadia. At December 31, 2018, the term loan was paid in full in connection with the Credit Agreement entered into during the fourth quarter of 2018, as discussed above.

At December 31, 2018, the Company had a total of $20.0 million of revolving loans outstanding on its credit facility, with an interest rate of 4.35%. After giving effect to the amount drawn on its credit facility, approximately $10.8 million of outstanding letters of credit and borrowing limits based on an advance multiple of adjusted EBITDA (as defined in the Credit Agreement), the Company had $137.4 million available for borrowing under its credit facility.

Senior Secured Credit Facility

Prior to October 31, 2018, the Company was party to a Credit Agreement, dated as of May 8, 2017 (the “2017 Credit Agreement”), with certain lenders and Capital One, National Association, as a lender and swing lender and as agent for all lenders. This credit facility totaled $250.0 million, replaced the Company’s previous senior secured credit facility, and terminated the Second Amended and Restated Credit and Guaranty Agreement, dated as of November 10, 2015, as modified by the May 24, 2016 amendment ( as amended, the “2015 Credit Agreement”), between the Company, certain lenders and Fifth Third Bank, as agent. The credit facility evidenced by the 2015 Credit Agreement included a $125.0 million revolving loan, a $45.0 million term loan and an $80.0 million delayed draw term loan.

On October 31, 2018, the Company repaid in full the outstanding debt balance of $102.6 million together with accrued interest of $0.5 million and amended and restated the 2017 Credit Agreement.

Income Taxes

12 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

10. Income Taxes

The current and deferred federal and state income tax provision from continuing operations, are comprised of the following:

	December 31,
	2019			2018			2017
	(Amounts in Thousands)
Current
Federal	$	5,876		$	2,883		$	5,828
State		2,442			1,562			1,078
Deferred
Federal		(734	)		(265	)		2,447
State		(225	)		(84	)		(95	)
Provision for income taxes	$	7,359		$	4,096		$	9,258

The tax effects of certain temporary differences between the Company’s book and tax bases of assets and liabilities give rise to significant portions of the deferred income tax assets (liabilities) at December 31, 2019 and 2018. The deferred tax assets (liabilities) consisted of the following:

	December 31,
	2019			2018
	(Amounts in Thousands)
Deferred tax assets
Long-term
Accounts receivable allowances	$	9,256		$	6,761
Accrued compensation		2,765			2,135
Accrued workers’ compensation		3,327			3,677
Transaction costs		1,311			1,020
Restructuring costs		135			160
Stock-based compensation		793			576
Operating lease liabilities		5,896			170
Other		584			279
Total long-term deferred tax assets		24,067			14,778
Deferred tax liabilities
Long-term
Goodwill and intangible assets		(15,079	)		(11,048	)
Property and equipment		(1,037	)		(903	)
Prepaid insurance		(534	)		(508	)
Operating lease assets, net		(5,606	)		—
Other		(164	)		(123	)
Total long-term deferred tax liabilities		(22,420	)		(12,582	)
Valuation allowance		—			—
Total net deferred tax assets (liabilities)	$	1,647		$	2,196

Management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers all available evidence in making this assessment.

A reconciliation for continuing operations of the statutory federal tax rate of 21.0%, 21.0% and 35.0% to the effective income tax rate, for the years ended December 31, 2019, 2018, and 2017, is summarized as follows:

	December 31,
	2019				2018				2017
Federal income tax at statutory rate		21.0		%		21.0		%		35.0		%
State and local taxes, net of federal benefit		6.4				6.3				5.1
Jobs tax credits, net		(8.3	)			(10.7	)			(6.5	)
162(m) disallowance for executive compensation		7.5				4.5				1.4
Nondeductible permanent items		0.7				2.2				0.4
Nondeductible penalties		1.3				—				—
2017 Tax Reform Act		—				—				9.3
Excess tax benefit		(6.7	)			(2.7	)			(0.6	)
Other		0.3				(0.5	)			(0.1	)
Effective income tax rate		22.2		%		20.1		%		44.0		%

The effective income tax rate was 22.2%, 20.1% and 44.0% for the years ended December 31, 2019, 2018 and 2017, respectively. The difference between our federal statutory and effective income tax rates is principally due to the inclusion of state taxes and non-deductible compensation, offset by an excess tax benefit and the use of federal employment tax credits.

The Company is subject to taxation in the jurisdictions in which it operates. The Company continues to remain subject to examination by U.S. federal authorities for the years 2016 through 2018 and for various state authorities for the years 2014 through 2018.

Stock Options And Restricted Stock Awards

12 Months Ended

Dec. 31, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Stock Options And Restricted Stock Awards

11. Stock Options and Restricted Stock Awards

The Board approved the 2017 Omnibus Incentive Plan (“the 2017 Plan”) as of April 27, 2017, which was approved by our shareholders on June 14, 2017. The 2017 Plan was intended to replace our existing incentive compensation plan, the 2009 Stock Incentive Plan (“the 2009 Plan”). All awards are now granted from the 2017 Plan. Outstanding awards under the 2009 Plan will continue to be governed by the 2009 Plan and the agreements under which they were granted.

The 2017 Plan allows us to grant performance-based incentive awards and equity-based awards (each an “Award”) to eligible employees, directors and consultants in the form of Stock Options, Stock Appreciation Rights, Restricted Stock, Deferred Stock Units/Restricted Stock Units, Other Stock Units or Performance Awards. The Company’s Board believes that the 2017 Plan is necessary to continue the Company’s effectiveness in attracting, motivating and retaining employees, directors and consultants with appropriate experience and to increase the grantees’ alignment of interest with the Company’s shareholders.

Under the 2017 Plan, Awards may be made in shares of our common stock. Subject to adjustment as provided by the terms of the 2017 Plan, the maximum aggregate number of shares of common stock with respect to which awards may be granted under the 2017 Plan will be 1,182,270, less the number of shares subject to awards that are granted pursuant to the 2009 Plan after March 31, 2017. The aggregate awards granted during any calendar year to any single Participant cannot exceed (i) 500,000 shares subject to stock options or stock appreciation rights (“SARs”) or (ii) 300,000 shares subject to Awards denominated in shares of common stock (whether or not settled in common stock). These individual annual limitations are cumulative in that any shares of common stock or cash for which Awards are permitted to be granted to a Participant during a fiscal year are not covered by an Award in that fiscal year, the number of shares of common stock will automatically increase in the subsequent fiscal years during the term of the 2017 Plan until the earlier of the time the increase has been granted to the Participant, or the end of the third fiscal year following the year to which such increase relates.

Any shares of common stock subject to an Award under the 2017 Plan that are forfeited, canceled, settled in cash or otherwise terminated without a distribution of shares to a Participant, or that are delivered by attestation or withheld by the Company in connection with an option exercise or the payment of any required income tax withholding upon an option exercise or the vesting of restricted stock, will be deemed available for Awards under the 2017 Plan. Additionally, any shares of common stock subject to an Award under the 2009 Plan that are forfeited, canceled, settled in cash or otherwise terminated without a distribution of shares to a participant, or that are delivered by attestation or withheld by the Company in connection with an option exercise or the payment of any required income tax withholding upon an option exercise or the vesting of restricted stock, will be deemed available for Awards under the 2017 Plan.

Stock options are awarded with a strike price equal to the fair market value based on the closing price of our common stock on the date of grant. Options granted typically vest over a service period ranging from three to four years and expire ten years from the date of grant. Restricted shares typically vest over a service period ranging from one to four years and expire ten years from date of grant.

The exercise prices of stock options outstanding on December 31, 2019 range from $4.62 to $87.80. Restricted stock awards are full-value awards. There were 0.7 million shares available for grant at December 31, 2019.

Stock Options

A summary of stock option activity and weighted average exercise price is as follows:

	For The Year Ended December 31,
	2019
	Options (Amounts in Thousands)			Weighted Average Exercise Price
Outstanding, beginning of period		683		$	29.60
Granted		92			79.21
Exercised		(126	)		25.11
Forfeited/Cancelled		(1	)		52.50
Outstanding, end of period		648		$	37.43

The weighted-average estimated fair value of employee stock options granted as calculated using the Black-Scholes Option Pricing Model in 2019, 2018 and 2017, and the related assumptions follow:

	For the Year Ended December 31,
	2019		2018		2017
	Grants		Grants		Grants
Weighted average fair value	$	29.78	$	14.72	$	12.97
Risk-free discount rate	1.72% - 2.29%		2.32% - 2.84%		1.67% - 1.85%
Expected life	4.2 - 4.4 years		4.1 - 4.2 years		3.6 - 4.2 years
Dividend yield		—		—		—
Volatility	43%		45%		47%

Stock option compensation expense totaled $2.5 million, $2.0 million and $1.1 million for the years ended December 31, 2019, 2018 and 2017, respectively. As of December 31, 2019, there was $4.9 million of total unrecognized compensation cost that is expected to be recognized over a weighted average period of 1.8 years.

The intrinsic value of vested and outstanding stock options was $16.7 million and $22.0 million, respectively, as of December 31, 2019.

As of December 31, 2019, there were 235,923 and 411,976 shares of stock options vested and unvested, respectively.

The intrinsic value of stock options exercised during the years ended December 31, 2019, 2018 and 2017 was $7.3 million, $1.8 million and $0.5 million, respectively.

Restricted Stock Awards

The following table summarizes the status of unvested restricted stock awards outstanding at December 31, 2019:

	For The Year Ended December 31,
	2019
	Restricted Stock Awards (Amounts in Thousands)			Weighted Average Grant Date Fair Value
Unvested restricted stock awards, beginning of period		149		$	36.10
Awarded		69			68.91
Vested		(66	)		35.58
Forfeited		(3	)		53.54
Unvested restricted stock awards, end of period		149		$	51.10

The fair market value of restricted stock awards that vested during the year ended December 31, 2019 was $4.2 million.

Restricted stock award compensation expense totaled $3.3 million, $2.1 million and $1.4 million for the years ended December 31, 2019, 2018 and 2017, respectively. As of December 31, 2019, there was $5.0 million of total unrecognized compensation cost that is expected to be recognized over a weighted average period of 1.6 years.

Employee Benefit Plans

12 Months Ended

Dec. 31, 2019

Compensation And Retirement Disclosure [Abstract]

Employee Benefit Plans

12. Employee Benefit Plans

The 401(k) retirement plan is a defined contribution plan that provides for matching contributions by the Company to all non-union employees. Matching contributions are discretionary and subject to change by management. Under the provisions of the 401(k) plan, employees can contribute up to the maximum percentage and limits allowable under the U.S. Revenue Code. The Company provided a matching contribution, equal to 6.0% of the employees’ contributions, totaling $0.2 million, $0.3 million and $44,000 for the years ended December 31, 2019, 2018 and 2017, respectively.

Commitments and Contingencies

12 Months Ended

Dec. 31, 2019

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

13. Commitments and Contingencies

Legal Proceedings

From time to time, the Company is subject to legal and/or administrative proceedings incidental to its business. It is the opinion of management that the outcome of pending legal and/or administrative proceedings will not have a material effect on our Consolidated Balance Sheets and Consolidated Statements of Income.

On January 20, 2016, the Company was served with a lawsuit filed in the United States District Court for the Northern District of Illinois against the Company and Cigna Corporation by Stop Illinois Marketing Fraud, LLC, a qui tam relator formed for the purpose of bringing this action. In the action, the plaintiff alleged, inter alia, violations of the federal False Claims Act relating primarily to allegations of violations of the federal Anti-Kickback Statute and allegedly improper referrals of patients from the Company’s home care division to the Company’s home health business, substantially all of which was sold in 2013. The plaintiff sought to recover damages, fees and costs under the federal False Claims Act including treble damages, civil penalties and its attorneys’ fees. The U.S. government declined to intervene. Plaintiff amended its complaint on April 4, 2016 to include additional allegations in support of its False Claims Act claims, including alleged violations of the federal Anti-Kickback Statute. The Company and Cigna Corporation filed a motion to dismiss the amended complaint on June 6, 2016. On February 3, 2017, the Court granted Cigna Corporation’s motion to dismiss in full, and granted the Company’s motion to dismiss in part allowing plaintiff another chance to amend its complaint. Plaintiff timely filed a second amended complaint on March 10, 2017, withdrawing its conspiracy claim under the Federal False Claims Act and adding an explicit claim under the Illinois False Claims Act for the same underlying kickback allegations. On April 7, 2017, the Company filed a partial motion to dismiss the Second Amended Complaint. On May 24, 2017, the State of Illinois filed notice that it was declining to intervene in the plaintiff’s claim under the Illinois False Claims Act. On March 21, 2018, the Court granted the Company’s motion to dismiss the Second Amended Complaint in part and narrowed the lawsuit to whether the federal False Claims Act was violated with respect to home health services provided at three senior living facilities in Illinois. On September 24, 2019, the parties reached an agreement to settle this lawsuit. In connection with the settlement, the Company recognized an expense of $0.6 million in discontinued operations for the year ended December 31, 2019. The lawsuit was dismissed in full on October 15, 2019.

Employment Agreements

During 2017, the Company entered into employment agreements with certain members of senior management. The terms of these agreements are up to four years with the potential to auto-renew and include non-competition and nondisclosure provisions, as well as provide for defined severance payments in the event of termination. On November 5, 2018 we amended and restated the employment agreements of each of our 2018 named executive officers in order to: (i) increase the amount of severance that would be payable on certain terminations of employment in connection with a change in control (as defined in the employment agreements), from two times annual compensation to three times annual compensation (as defined in the employment agreements) in the case of our chief executive officer, and from one times annual compensation to two times annual compensation (as defined in the employment agreements) in the case of our other named executive officers; (ii) provide that the enhanced severance for terminations of employment in connection with a change in control would be payable if the named executive officers self-terminated for good reason (as defined in the employment agreements); (iii) stipulate that severance for terminations of employment in connection with a change in control would include any unpaid bonus for a performance period completed prior to termination (the chief executive officer already had this right); and (iv) adjust the duration of non-competition and non-solicitation periods to match the number of years of annual compensation that the named executive officer would receive in severance.

A substantial percentage of the Company’s workforce is represented by the Service Employees International Union (“SEIU”) through local collective bargaining agreements. These agreements are re-negotiated at various intervals. These negotiations are often initiated when the Company receives increases in hourly rates from various state agencies. Upon expiration of these collective bargaining agreements, the Company may not be able to negotiate labor agreements on satisfactory terms with these labor unions.

Segment Information

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Segment Information

14. Segment Information

Operating segments are defined as components of a company that engage in business activities from which it may earn revenues and incur expenses, and for which separate financial information is available and is regularly reviewed by the Company’s chief operating decision makers, to assess the performance of the individual segments and make decisions about resources to be allocated to the segments. The Company operates as a multi-state provider of three distinct but related business segments providing in-home services.

In its personal care segment, the Company provides non-medical assistance with activities of daily living, primarily to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. In its hospice segment, the Company provides physical, emotional and spiritual care for people who are terminally ill as well as related services for their families. In its home health segment, the Company provides services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational and speech therapy.

The tables below set forth information about the Company’s reportable segments for the years ended December 31, 2019, 2018 and 2017 along with the items necessary to reconcile the segment information to the totals reported in the accompanying consolidated financial statements. Segment assets are not reviewed by the Company’s chief operating decision maker function and therefore are not disclosed below.

Segment operating income consists of the net service revenues generated by a segment, less the direct costs of service revenues and general and administrative expenses that are incurred directly by the segment. Unallocated general and administrative costs are those costs for functions performed in a centralized manner and therefore not attributable to a particular segment. These costs include accounting, finance, human resources, legal, information technology, corporate office support and facility costs and overall corporate management.

	For the Year Ended December 31, 2019
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	580,728	$	53,601	$	14,462	$	648,791
Cost of services revenues		432,413		27,203		9,937		469,553
Gross profit		148,315		26,398		4,525		179,238
General and administrative expenses		56,645		12,304		3,199		72,148
Provision for doubtful accounts		242		95		6		343
Segment operating income	$	91,428	$	13,999	$	1,320	$	106,747

	For the Year Ended December 31, 2018
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	490,941	$	18,850	$	6,856	$	516,647
Cost of services revenues		365,264		10,010		4,569		379,843
Gross profit		125,677		8,840		2,287		136,804
General and administrative expenses		44,463		3,737		1,543		49,743
Provision for doubtful accounts		265		5		2		272
Segment operating income	$	80,949	$	5,098	$	742	$	86,789

	For the Year Ended December 31, 2017
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	425,994	$	—	$	—	$	425,994
Cost of services revenues		310,119		—		—		310,119
Gross profit		115,875		—		—		115,875
General and administrative expenses		35,655		—		—		35,655
Provision for doubtful accounts		9,524		—		—		9,524
Segment operating income	$	70,696	$	—	$	—	$	70,696

	For the Years Ended December 31,
	(Amounts in Thousands)
	2019			2018			2017
Segment reconciliation:
Total segment operating income	$	106,747		$	86,789		$	70,696

Items not allocated at segment level:
Other general and administrative expenses		61,421			55,282			41,247
Depreciation and amortization		10,574			8,642			6,663
Loss (gain) on sale of assets		—			38			(2,467	)
Interest income		(1,523	)		(2,592	)		(66	)
Interest expense		3,105			5,016			4,472
Other income		—			—			(217	)
Income before income taxes	$	33,170		$	20,403		$	21,064

Significant Payors

12 Months Ended

Dec. 31, 2019

Significant Payors [Abstract]

Significant Payors

15. Significant Payors

For 2019, 2018 and 2017, our revenue by payor type was as follows:

	Personal Care
	2019					2018 ⁽¹⁾					2017 ⁽¹⁾
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
State, local and other governmental programs	$	303,479		52.2	%	$	285,973		58.2	%	$	273,525		64.2	%
Managed care organizations		239,559		41.3			173,391		35.3			140,993		33.1
Private pay		21,765		3.7			20,003		4.1			8,739		2.1
Commercial insurance		9,204		1.6			6,173		1.3			2,737		0.6
Other		6,721		1.2			5,401		1.1			—		—
Total personal care segment net service revenues	$	580,728		100.0	%	$	490,941		100.0	%	$	425,994		100.0	%

	Hospice
	2019					2018
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	49,649		92.6	%	$	17,652		93.6	%
Managed care organizations		2,768		5.2			1,047		5.6
Other		1,184		2.2			151		0.8
Total hospice segment net service revenues	$	53,601		100.0	%	$	18,850		100.0	%

	Home Health
	2019					2018
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	11,218		77.6	%	$	6,034		88.0	%
Managed care organizations		2,942		20.3			752		11.0
Other		302		2.1			70		1.0
Total home health segment net service revenues	$	14,462		100.0	%	$	6,856		100.0	%

The Company derives a significant amount of its net service revenues from its operations in Illinois, New York and New Mexico. The percentages of total revenue for each of these significant states for 2019, 2018 and 2017 were as follows:

	Personal Care
	2019					2018 ⁽¹⁾					2017 ⁽¹⁾
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Illinois	$	247,524		42.6	%	$	232,518		47.3	%	$	224,257		52.6	%
New York		108,403		18.7			65,117		13.3			58,360		13.7
New Mexico		75,666		13.0			58,914		12.0			37,588		8.8
All other states		149,135		25.7			134,392		27.4			105,789		24.9
Total personal care segment net service revenues	$	580,728		100.0	%	$	490,941		100.0	%	$	425,994		100.0	%

	Hospice
	2019					2018
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	38,790		72.4	%	$	18,850		100.0	%
All other states		14,811		27.6			—		—
Total hospice segment net service revenues	$	53,601		100.0	%	$	18,850		100.0	%

	Home Health
	2019					2018
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	14,462		100.0	%	$	6,856		100.0	%
Total home health segment net service revenues	$	14,462		100.0	%	$	6,856		100.0	%

A substantial portion of the Company’s net service revenues and accounts receivables are derived from services performed for state and local governmental agencies. We derive a significant amount of our net service revenues in Illinois, which represented 38.2%, 45.0% and 52.6% of our net service revenues for the years ended December 31, 2019, 2018 and 2017, respectively. The Illinois Department on Aging, the largest payor program for the Company’s Illinois personal care operations, accounted for 25.3%, 31.7% and 36.5% of the Company’s net service revenues for 2019, 2018, and 2017, respectively.

The related receivables due from the Illinois Department on Aging represented 25.1% and 23.1% of the Company’s net accounts receivable at December 31, 2019 and 2018, respectively.

Concentration of Cash

12 Months Ended

Dec. 31, 2019

Risks And Uncertainties Abstract

Concentration of Cash

16. Concentration of Cash

The Company owns financial instruments that potentially subject the Company to significant concentrations of credit risk include cash. The Company maintains cash with financial institutions which, at times, may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk on cash.

Unaudited Summarized Quarterly Financial Information

12 Months Ended

Dec. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Unaudited Summarized Quarterly Financial Information

17. Unaudited Summarized Quarterly Financial Information

The following is a summary of the Company’s unaudited quarterly results of operations. See Note 2. Revision of Previously Issued Financial Statements.

	Year Ended December 31, 2019									Year Ended December 31, 2018
	Dec. 31		Sept. 30			Jun. 30		Mar. 31		Dec. 31		Sept. 30		Jun. 30		Mar. 31
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	192,376	$	168,993		$	148,915	$	138,507	$	139,288	$	137,341	$	130,892	$	109,126
Gross profit		57,542		45,176			39,693		36,827		37,429		36,415		35,377		27,583
Operating income from continuing operations		14,530		7,335			7,391		5,496		6,428		5,613		6,547		4,239
Net income from continuing operations		10,737		5,486			5,292		4,296		4,266		3,358		4,052		4,631
(Loss) earnings from discontinued operations		—		(574	)		—		—		126		—		—		—
Net income	$	10,737	$	4,912		$	5,292	$	4,296	$	4,392	$	3,358	$	4,052	$	4,631
Average shares outstanding:
Basic		15,435		13,766			13,044		12,995		12,964		12,179		11,533		11,502
Diluted		15,881		14,203			13,433		13,381		13,381		12,569		11,838		11,696
Income per common share:
Basic
Continuing operations	$	0.70	$	0.40		$	0.41	$	0.33	$	0.33	$	0.28	$	0.35	$	0.40
Discontinued operations		—		(0.04	)		—		—		0.01		—		—		—
Basic net income per share	$	0.70	$	0.36		$	0.41	$	0.33	$	0.34	$	0.28	$	0.35	$	0.40
Diluted net income per share
Continuing operations	$	0.68	$	0.39		$	0.39	$	0.32	$	0.32	$	0.27	$	0.34	$	0.40
Discontinued operations		—		(0.04	)		—		—		0.01		—		—		—
Diluted net income per share	$	0.68	$	0.35		$	0.39	$	0.32	$	0.33	$	0.27	$	0.34	$	0.40

As described in Note 2 above, the Company identified immaterial errors in the Company’s previously issued Consolidated Financial Statements related to implicit price concessions and provision for doubtful accounts. The correction reflects the impact on the Company’s income tax provision and related accounts as a result of correcting for the immaterial error as discussed above. Additionally, the Company identified and corrected immaterial unrelated income tax items impacting deferred tax assets and the reserve for uncertain tax positions, and other immaterial items.

The following are the effects of the corrections, of the immaterial errors on the Company’s unaudited quarterly results of operations. The unaudited quarterly information will be revised in conjunction with the future filing of the Company’s unaudited quarterly financial statements for each of the 2020 quarterly periods.

	For the Three Months Ended March 31, 2019							For the Three Months Ended March 31, 2018
	Previously reported		Revision			As Revised		Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	139,254	$	(747	)	$	138,507	$	109,476	$	(350	)	$	109,126
Gross profit		37,574		(747	)		36,827		27,933		(350	)		27,583
Operating income from continuing operations		6,243		(747	)		5,496		4,589		(350	)		4,239
Net income from continuing operations		4,862		(566	)		4,296		4,886		(255	)		4,631
Net income		4,862		(566	)		4,296		4,886		(255	)		4,631
Income per common share:
Basic	$	0.37	$	(0.04	)	$	0.33	$	0.42	$	(0.02	)	$	0.40
Diluted	$	0.36	$	(0.04	)	$	0.32	$	0.42	$	(0.02	)	$	0.40

	For the Three Months Ended June 30, 2019							For the Three Months Ended June 30, 2018
	Previously reported		Revision			As Revised		Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	149,692	$	(777	)	$	148,915	$	131,258	$	(366	)	$	130,892
Gross profit		40,470		(777	)		39,693		35,743		(366	)		35,377
Operating income from continuing operations		7,713		(322	)		7,391		6,913		(366	)		6,547
Net income from continuing operations		5,518		(226	)		5,292		4,318		(266	)		4,052
Net income		5,518		(226	)		5,292		4,318		(266	)		4,052
Income per common share:
Basic	$	0.42	$	(0.01	)	$	0.41	$	0.37	$	(0.02	)	$	0.35
Diluted	$	0.41	$	(0.02	)	$	0.39	$	0.36	$	(0.02	)	$	0.34

	For the Three Months Ended September 30, 2019							For the Three Months Ended September 30, 2018
	Previously reported		Revision			As Revised		Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	169,803	$	(810	)	$	168,993	$	137,716	$	(375	)	$	137,341
Gross profit		45,986		(810	)		45,176		36,790		(375	)		36,415
Operating income from continuing operations		7,280		55			7,335		5,988		(375	)		5,613
Net income from continuing operations		5,441		45			5,486		3,631		(273	)		3,358
Net income		4,867		45			4,912		3,631		(273	)		3,358
Income per common share:
Basic	$	0.36	$	—		$	0.36	$	0.29	$	(0.01	)	$	0.28
Diluted	$	0.34	$	0.01		$	0.35	$	0.28	$	(0.01	)	$	0.27

	For the Three Months Ended December 30, 2018
	Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	139,669	$	(381	)	$	139,288
Gross profit		37,810		(381	)		37,429
Operating income from continuing operations		6,809		(381	)		6,428
Net income from continuing operations		4,542		(276	)		4,266
Net income		4,668		(276	)		4,392
Income per common share:
Basic	$	0.36	$	(0.02	)	$	0.34
Diluted	$	0.35	$	(0.02	)	$	0.33

Subsequent Events

12 Months Ended

Dec. 31, 2019

Subsequent Events [Abstract]

Subsequent Events

18. Subsequent Events

On February 17, 2020, the Company signed an eleven year lease agreement to expand its Frisco support center from 31,000 square feet to approximately 75,000 square feet which will result in an increase in the operating lease asset, net and operating lease liability by approximately $13 million and $17 million, respectively. The Frisco support staff is expected to move during the third quarter of 2020.

On January 31, 2020, the Secretary of the U.S. Department of Health and Human Services (“HHS”) declared a national public health emergency due to a novel coronavirus. In March 2020, the World Health Organization declared the outbreak of COVID-19, a disease caused by this novel coronavirus, a pandemic. This disease continues to spread throughout the United States and other parts of the world. It is impossible to predict the effect and ultimate impact of the COVID-19 pandemic as the situation is rapidly evolving. The spread of COVID-19 has caused public health officials to recommend and mandate precautions to mitigate the spread of the virus, including the closure of public facilities and parks, schools, restaurants, many businesses and other locations of public assembly. Although many of these restrictions have eased across the country and certain of these locations have reopened, to varying degrees,

the COVID-19 pandemic has yet to show substantial signs of decline in the U.S. Some areas are re-imposing closures and other restrictions due to increasing rates of COVID-19 cases. There are no reliable estimates of how long the pandemic will last, how many people are likely to be affected by it or the duration or types of restrictions that will be imposed. For that reason, we are unable to predict the long-term impact of the pandemic on our business at this time.

In April 2020, the Company received grants in an aggregate principal amount of $6.9 million from the Public Health and Social Services Emergency Fund (“Relief Fund”) under the Coronavirus Aid, Relief and Economic Security Act of 2020 (the “CARES Act”) as part of the automatic general distributions by HHS, for which it did not apply. The Company returned these funds in June 2020.

On July 1, 2020, we completed the acquisition of A Plus Health Care, Inc. (“A Plus”) for approximately $12.2 million, with funding provided by cash on hand. With the purchase of A Plus, we expanded our personal care services in the state of Montana. The Company is currently assessing the fair value of identifiable net assets acquired.

Valuation And Qualifying Accounts

12 Months Ended

Dec. 31, 2019

Valuation And Qualifying Accounts [Abstract]

Valuation And Qualifying Accounts

VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II

(Amounts in Thousands)

Allowance for doubtful accounts	Balance at beginning of period		Additions/ charges		Deductions*		Balance at end of period
Year ended December 31, 2019
Allowance for doubtful accounts	$	945		343		326	$	962
Year ended December 31, 2018
Allowance for doubtful accounts	$	18,749		272		18,076	$	945
Year ended December 31, 2017
Allowance for doubtful accounts	$	14,460		9,524		5,235	$	18,749

*	Write-offs, net of recoveries

With the adoption of ASU 2014-09, Revenue from Contracts with Customers, in 2018 and subsequent periods, subsequent adjustments that are determined to be the result of an adverse change in the payor’s ability to pay are recognized as provision for doubtful accounts. We recorded $11.0 million for the year ended December 31, 2018 as a reduction to revenue that would have been recorded as provision for doubtful accounts under the prior revenue recognition guidance. As described in Note 2 above, the Company identified immaterial errors in the Company’s previously issued Consolidated Financial Statements related to the provision for doubtful accounts. The cumulative effect of those adjustments increased the allowance for doubtful accounts as of December 31, 2018 and 2017, by $0.3 million and $8.2 million, respectively, of which $7.9 million resulted in an increase in deductions for the year ended December 31, 2018.

Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Principles of Consolidation

All intercompany balances and transactions have been eliminated in consolidation.

Discontinued Operations

Reclassification of Prior Period Balances

Revenue Recognition

Personal Care

Hospice Revenue

Home Health Revenue

Accounts Receivable and Allowances

Property and Equipment

Computer equipment		3—5 years
Furniture and equipment		5—7 years
Transportation equipment		5 years
Computer software		3—10 years
Leasehold improvements		Lesser of useful life or lease term

Goodwill and Intangible Assets

Debt Issuance Costs

Workers' Compensation Program

Workers’ Compensation Program

Interest Income

Interest Expense

Income Tax Expense

Stock-Based Compensation

Stock-based Compensation

Diluted Net Income Per Common Share

Estimates

Fair Value Measurements

Going Concern

Recently Issued and Adopted Accounting Pronouncements

Recently Adopted Accounting Pronouncements

Recently Issued Accounting Pronouncements

Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Estimated Useful Lives of Property and Equipment

The estimated useful lives of the property and equipment are as follows:

Computer equipment		3—5 years
Furniture and equipment		5—7 years
Transportation equipment		5 years
Computer software		3—10 years
Leasehold improvements		Lesser of useful life or lease term

Revision of Previously Issued Financial Statements (Tables)

12 Months Ended

Dec. 31, 2019

Accounting Changes And Error Corrections [Abstract]

Schedule of Error Corrections and Prior Period Adjustments

Consolidated Balance Sheet as of December 31, 2018 (in thousands):

	As
	Previously					As
	Reported		Revision			Revised
Accounts receivable, net of allowances	$	108,000	$	(9,684	)	$	98,316
Prepaid expenses and other current assets		7,098		194			7,292
Deferred tax assets, net		—		2,196			2,196
Total assets		355,388		(7,294	)		348,094
Deferred tax liabilities, net		494		(494	)		—
Other long-term liabilities		635		242			877
Total liabilities		79,855		(252	)		79,603
Total stockholders’ equity		275,533		(7,042	)		268,491
Total liabilities and stockholders’ equity	$	355,388	$	(7,294	)		348,094

Consolidated Statement of Stockholders’ Equity Opening Balance:

	Common Stock				Additional Paid in Capital		Retained Earnings			Total Stockholders' Equity
	Shares		Amount
Balance at January 1, 2017		11,527	$	12	$	92,253	$	66,653		$	158,918
Revision				—		—		(4,244	)		(4,244	)
Balance at January 1, 2017, as revised		11,527	$	12	$	92,253	$	62,409		$	154,674

Consolidated Statements of Income (in thousands):

	For the Years Ended December 31,
	2018							2017
	As							As
	Previously					As		Previously					As
	Reported		Revision			Revised		Reported		Revision			Revised
Net service revenues	$	518,119	$	(1,472	)	$	516,647	$	425,994	$	—		$	425,994
Gross profit		138,276		(1,472	)		136,804		115,875		—			115,875
Provision for doubtful accounts		272		—			272		8,409		1,115			9,524
Total operating expenses		113,977		—			113,977		89,507		1,115			90,622
Operating income from continuing operations		24,299		(1,472	)		22,827		26,368		(1,115	)		25,253
Income from continuing operations before income taxes		21,875		(1,472	)		20,403		22,179		(1,115	)		21,064
Income tax expense		4,498		(402	)		4,096		8,645		613			9,258
Net income from continuing operations		17,377		(1,070	)		16,307		13,534		(1,728	)		11,806
Net income	$	17,503	$	(1,070	)	$	16,433	$	13,681	$	(1,728	)	$	11,953

Basic income per share from continuing operations		1.44		(0.09	)		1.35		1.18		(0.15	)		1.03
Diluted income per share from continuing operations	$	1.40	$	(0.08	)	$	1.32	$	1.16	$	(0.14	)	$	1.02

Basic income per share		1.45		(0.09	)		1.36		1.19		(0.15	)		1.04
Diluted income per share	$	1.41	$	(0.08	)	$	1.33	$	1.17	$	(0.14	)	$	1.03

Consolidated Statements of Cash Flows (in thousands):

	For the Years Ended December 31,
	2018									2017
	As									As
	Previously						As			Previously						As
	Reported			Revision			Revised			Reported			Revision			Revised
Net income	$	17,503		$	(1,070	)	$	16,433		$	13,681		$	(1,728	)	$	11,953
Provision for doubtful accounts		272			—			272			8,409			1,115			9,524
Deferred income taxes		(43	)		(332	)		(375	)		1,754			716			2,470
Prepaid expenses and other current assets		1,964			(312	)		1,652			(2,364	)		(103	)		(2,467	)
Accrued expenses and other liabilities		(1,107	)		242			(865	)		1,779			—			1,779
Accounts receivable		(2,169	)		1,472			(697	)		19,412			—			19,412
Net cash provided by operating activities	$	33,203		$	—		$	33,203		$	52,771		$	—		$	52,771

	For the Three Months Ended March 31, 2019							For the Three Months Ended March 31, 2018
	Previously reported		Revision			As Revised		Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	139,254	$	(747	)	$	138,507	$	109,476	$	(350	)	$	109,126
Gross profit		37,574		(747	)		36,827		27,933		(350	)		27,583
Operating income from continuing operations		6,243		(747	)		5,496		4,589		(350	)		4,239
Net income from continuing operations		4,862		(566	)		4,296		4,886		(255	)		4,631
Net income		4,862		(566	)		4,296		4,886		(255	)		4,631
Income per common share:
Basic	$	0.37	$	(0.04	)	$	0.33	$	0.42	$	(0.02	)	$	0.40
Diluted	$	0.36	$	(0.04	)	$	0.32	$	0.42	$	(0.02	)	$	0.40

	For the Three Months Ended June 30, 2019							For the Three Months Ended June 30, 2018
	Previously reported		Revision			As Revised		Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	149,692	$	(777	)	$	148,915	$	131,258	$	(366	)	$	130,892
Gross profit		40,470		(777	)		39,693		35,743		(366	)		35,377
Operating income from continuing operations		7,713		(322	)		7,391		6,913		(366	)		6,547
Net income from continuing operations		5,518		(226	)		5,292		4,318		(266	)		4,052
Net income		5,518		(226	)		5,292		4,318		(266	)		4,052
Income per common share:
Basic	$	0.42	$	(0.01	)	$	0.41	$	0.37	$	(0.02	)	$	0.35
Diluted	$	0.41	$	(0.02	)	$	0.39	$	0.36	$	(0.02	)	$	0.34

	For the Three Months Ended September 30, 2019							For the Three Months Ended September 30, 2018
	Previously reported		Revision			As Revised		Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	169,803	$	(810	)	$	168,993	$	137,716	$	(375	)	$	137,341
Gross profit		45,986		(810	)		45,176		36,790		(375	)		36,415
Operating income from continuing operations		7,280		55			7,335		5,988		(375	)		5,613
Net income from continuing operations		5,441		45			5,486		3,631		(273	)		3,358
Net income		4,867		45			4,912		3,631		(273	)		3,358
Income per common share:
Basic	$	0.36	$	—		$	0.36	$	0.29	$	(0.01	)	$	0.28
Diluted	$	0.34	$	0.01		$	0.35	$	0.28	$	(0.01	)	$	0.27

	For the Three Months Ended December 30, 2018
	Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	139,669	$	(381	)	$	139,288
Gross profit		37,810		(381	)		37,429
Operating income from continuing operations		6,809		(381	)		6,428
Net income from continuing operations		4,542		(276	)		4,266
Net income		4,668		(276	)		4,392
Income per common share:
Basic	$	0.36	$	(0.02	)	$	0.34
Diluted	$	0.35	$	(0.02	)	$	0.33

Leases (Tables)

12 Months Ended

Dec. 31, 2019

Leases [Abstract]

Amounts Reported in Condensed Consolidated Balance Sheets for Operating Leases

Amounts reported in the Consolidated Balance Sheets as of December 31, 2019 for our operating leases were as follows:

	December 31, 2019
	(Amounts in Thousands)
Operating lease assets, net	$	21,111

Short-term operating lease liabilities (in accrued expenses)		7,234
Long-term operating lease liabilities		14,301
Total operating lease liabilities	$	21,535

Components of Lease Cost Reported in General and Administrative Expenses in Condensed Consolidated Statements of Income

Components of lease cost were reported in general and administrative expenses in the Consolidated Statements of Income as follows:

	For the Year Ended December 31, 2019
	(Amounts in Thousands)
Operating lease costs	$	7,219
Short-term lease costs		585
Total lease cost	$	7,804

Schedule of Weighted Average Remaining Lease Terms and Discount Rates

Weighted average remaining lease terms and discount rates for the year ended December 31, 2019 were as follows:

	2019
Operating leases:
Weighted average remaining lease term		3.42
Weighted average discount rate		5.14	%

Summary of Remaining Operating Lease Payments

A summary of our remaining operating lease payments as of December 31, 2019 were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in 12-month period ended December 31,
2020	$	7,975
2021		6,935
2022		4,331
2023		2,526
2024		1,437
Thereafter		389
Total future minimum rental commitments		23,593
Less: Imputed interest		(2,058	)
Total lease liabilities	$	21,535

Summary of Future Minimum Operating Lease Payments

The future minimum operating lease payments on non-cancelable leases as of December 31, 2018 under the accounting standards in effect as of that period were as follows:

	Operating Leases
	(Amounts in Thousands)
Due in 12-month period ended December 31,
2019	$	6,374
2020		4,820
2021		3,460
2022		2,377
2023		2,130
Thereafter		1,382
Total future minimum rental commitments	$	20,543

Supplemental Cash Flows Information

	For the Year Ended December 31, 2019
	(Amounts in Thousands)
Supplemental Cash Flows Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	7,574

Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	10,299

Acquisitions (Tables)

12 Months Ended

Dec. 31, 2019

Hospice Partners [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	112,484
Identifiable intangible assets		18,090
Cash		5,705
Property and equipment		164
Accounts receivable		6,506
Operating lease assets, net		2,518
Other assets		632
Accounts payable		(1,618	)
Accrued expenses		(4,650	)
Accrued payroll		(1,108	)
Deferred tax liability		(1,540	)
Long-term operating lease liabilities		(1,615	)
Total purchase price	$	135,568

Alliance Home Health Care [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	16,646
Identifiable intangible assets		5,422
Cash		260
Accounts receivable		1,665
Accounts payable		(299	)
Other liabilities		(236	)
Total purchase price	$	23,458

VIP Health Care Services [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are preliminary and subject to completion of working capital adjustments, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	10,550
Identifiable intangible assets		15,370
Cash		110
Accounts receivable		6,058
Operating lease assets, net		2,278
Other assets		30
Property and equipment		27
Accounts payable		(462	)
Accrued expenses		(770	)
Accrued payroll		(1,742	)
Long-term operating lease liabilities		(1,531	)
Total purchase price	$	29,918

Ambercare Corporation [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	28,831
Cash		12,028
Identifiable intangible assets		9,944
Accounts receivable		6,512
Other assets		442
Property and equipment		154
Accrued expenses		(4,073	)
Deferred tax liability		(2,138	)
Financing lease		(75	)
Accounts payable		(3	)
Total purchase price	$	51,622

Arcadia Home Care And Staffing [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	13,072
Accounts receivable		5,317
Identifiable intangible assets		2,264
Property and equipment		155
Other assets		92
Accrued expenses		(1,540	)
Accounts payable		(508	)
Total purchase price	$	18,852

Lifestyle Options, Inc. [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	2,751
Identifiable intangible assets		1,152
Accounts receivable		573
Other assets		32
Property and equipment		18
Accrued expenses		(291	)
Accounts payable		(105	)
Total purchase price	$	4,130

Sun Cities Homecare [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	1,089
Identifiable intangible assets		682
Accounts receivable		254
Cash		321
Other assets		10
Accrued expenses		(86	)
Accounts payable		(14	)
Total purchase price	$	2,256

Options Home Care [Member]

Business Acquisition [Line Items]

Schedule of Fair Values of Assets and Liabilities

Based upon management’s valuations, which are now final, the fair values of the assets and liabilities are as follows:

	Total (Amounts in Thousands)
Goodwill	$	16,671
Identifiable intangible assets		5,324
Accounts receivable		1,084
Cash		205
Other assets		41
Accrued liabilities		(701	)
Total purchase price	$	22,624

Hospice Partners, Alliance, VIP, Ambercare, Arcadia, LifeStyle, Sun Cities and Options Home Care [Member]

Business Acquisition [Line Items]

Unaudited Pro Forma Condensed Consolidated Income Statement Information

	For the Years Ended December 31, (Amounts in Thousands, Unaudited)
	2019		2018		2017
Net service revenues	$	726,727	$	550,326	$	441,858
Operating income from continuing operations		46,571		36,985		28,103
Net income from continuing operations		35,748		24,346		15,010
Net income per common share from continuing operations
Basic income per share	$	2.59	$	2.02	$	1.31
Diluted income per share	$	2.51	$	1.97	$	1.29

Property and Equipment (Tables)

12 Months Ended

Dec. 31, 2019

Property Plant And Equipment [Abstract]

Schedule of Property and Equipment

Property and equipment consisted of the following:

	December 31,
	2019			2018
	(Amounts in Thousands)
Computer equipment	$	5,304		$	3,768
Furniture and equipment		3,410			3,161
Transportation equipment		157			156
Leasehold improvements		3,749			2,962
Computer software		9,563			6,712
		22,183			16,759
Less: accumulated depreciation and amortization		(10,027	)		(6,101	)
	$	12,156		$	10,658

Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2019

Goodwill And Intangible Assets Disclosure [Abstract]

Summary of Goodwill and Related Adjustments

A summary of goodwill and related adjustments is provided below:

	Goodwill
	Personal Care			Hospice		Home Health		Total
	(Amounts In Thousands)
Goodwill at December 31, 2017	$	90,339		$	—	$	—	$	90,339
Additions for acquisitions		22,135			22,200		865		45,200
Adjustments to previously recorded goodwill		(97	)		—		—		(97	)
Goodwill at December 31, 2018		112,377			22,200		865		135,442
Additions for acquisitions		14,368			124,750		941		140,059
Adjustments to previously recorded goodwill		(168	)		33		2		(133	)
Goodwill at December 31, 2019	$	126,577		$	146,983	$	1,808	$	275,368

Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset

The carrying amount and accumulated amortization of each identifiable intangible asset category consisted of the following at December 31, 2019 and 2018:

	Customer and referral relationships			Trade names and trademarks			Non- competition agreements			State Licenses			Total
	(Amounts in Thousands)
Intangible assets with indefinite lives	$	—		$	—		$	—		$	13,306		$	13,306
Intangible assets subject to amortization:
Gross carrying amount		48,028			31,036			4,655			12,020			95,739
Accumulated amortization		(35,665	)		(12,941	)		(2,234	)		(1,126	)		(51,966	)
Intangible assets subject to amortization, net		12,363			18,095			2,421			10,894			43,773
Net balance at December 31, 2019	$	12,363		$	18,095		$	2,421		$	24,200		$	57,079

Intangible assets with indefinite lives	$	—		$	—		$	—		$	2,871		$	2,871
Intangible assets subject to amortization:
Gross carrying amount		42,356			21,551			2,155			241			66,303
Accumulated amortization		(32,752	)		(10,638	)		(1,981	)		(19	)		(45,390	)
Intangible assets subject to amortization, net		9,604			10,913			174			222			20,913
Net balance at December 31, 2018	$	9,604		$	10,913		$	174		$	3,093		$	23,784

Schedule of Future Amortization of Intangible Assets

The estimated future intangible amortization expense is as follows:

For the year ended December 31,	Total (Amount in Thousands)
2020	$	6,935
2021		6,440
2022		5,419
2023		4,936
2024		4,692
Thereafter		15,351
Total, intangible assets subject to amortization	$	43,773

Details of Certain Balance Sheet Accounts (Tables)

12 Months Ended

Dec. 31, 2019

Details Of Certain Balance Sheet Accounts [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets consist of the following:

	December 31,
	2019		2018
	(Amounts in Thousands)
Prepaid workers’ compensation and liability insurance	$	2,040	$	1,840
Workers’ compensation insurance receivable		1,989		1,692
Health insurance receivable		1,567		564
Other		2,397		3,196
Total prepaid expenses and other current assets	$	7,993	$	7,292

Schedule of Accrued Expenses

Accrued expenses consisted of the following:

	December 31,
	2019		2018
	(Amounts in Thousands)
Current portion of operating lease liabilities	$	7,234	$	—
Accrued health insurance		4,140		3,926
Accrued professional fees		2,517		2,260
Accrued payroll taxes		1,843		769
Other		6,695		4,631
Total accrued expenses	$	22,429	$	11,586

Long-Term Debt (Tables)

12 Months Ended

Dec. 31, 2019

Long Term Debt [Abstract]

Schedule of Long-Term Debt

	December 31,
	2019			2018
	(Amounts in Thousands)
Revolving loan under the credit facility	$	43,458		$	20,000
Term loan under the credit facility		18,865			—
Financing leases		21			81
Less unamortized issuance costs		(2,452	)		(2,797	)
Total		59,892			17,284
Less current maturities		(728	)		(62	)
Long-term debt	$	59,164		$	17,222

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Current and Deferred Federal and State Income Tax Provision from Continuing Operations

The current and deferred federal and state income tax provision from continuing operations, are comprised of the following:

	December 31,
	2019			2018			2017
	(Amounts in Thousands)
Current
Federal	$	5,876		$	2,883		$	5,828
State		2,442			1,562			1,078
Deferred
Federal		(734	)		(265	)		2,447
State		(225	)		(84	)		(95	)
Provision for income taxes	$	7,359		$	4,096		$	9,258

Deferred Tax Assets And Liabilities

	December 31,
	2019			2018
	(Amounts in Thousands)
Deferred tax assets
Long-term
Accounts receivable allowances	$	9,256		$	6,761
Accrued compensation		2,765			2,135
Accrued workers’ compensation		3,327			3,677
Transaction costs		1,311			1,020
Restructuring costs		135			160
Stock-based compensation		793			576
Operating lease liabilities		5,896			170
Other		584			279
Total long-term deferred tax assets		24,067			14,778
Deferred tax liabilities
Long-term
Goodwill and intangible assets		(15,079	)		(11,048	)
Property and equipment		(1,037	)		(903	)
Prepaid insurance		(534	)		(508	)
Operating lease assets, net		(5,606	)		—
Other		(164	)		(123	)
Total long-term deferred tax liabilities		(22,420	)		(12,582	)
Valuation allowance		—			—
Total net deferred tax assets (liabilities)	$	1,647		$	2,196

Reconciliation of Statutory Federal Tax Rate

	December 31,
	2019				2018				2017
Federal income tax at statutory rate		21.0		%		21.0		%		35.0		%
State and local taxes, net of federal benefit		6.4				6.3				5.1
Jobs tax credits, net		(8.3	)			(10.7	)			(6.5	)
162(m) disallowance for executive compensation		7.5				4.5				1.4
Nondeductible permanent items		0.7				2.2				0.4
Nondeductible penalties		1.3				—				—
2017 Tax Reform Act		—				—				9.3
Excess tax benefit		(6.7	)			(2.7	)			(0.6	)
Other		0.3				(0.5	)			(0.1	)
Effective income tax rate		22.2		%		20.1		%		44.0		%

Stock Options And Restricted Stock Awards (Tables)

12 Months Ended

Dec. 31, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Summary of Stock Option Activity and Weighted Average Exercise Price

	For The Year Ended December 31,
	2019
	Options (Amounts in Thousands)			Weighted Average Exercise Price
Outstanding, beginning of period		683		$	29.60
Granted		92			79.21
Exercised		(126	)		25.11
Forfeited/Cancelled		(1	)		52.50
Outstanding, end of period		648		$	37.43

Weighted-Average Estimated Fair Value of Employee Stock Options Granted

	For the Year Ended December 31,
	2019		2018		2017
	Grants		Grants		Grants
Weighted average fair value	$	29.78	$	14.72	$	12.97
Risk-free discount rate	1.72% - 2.29%		2.32% - 2.84%		1.67% - 1.85%
Expected life	4.2 - 4.4 years		4.1 - 4.2 years		3.6 - 4.2 years
Dividend yield		—		—		—
Volatility	43%		45%		47%

Summary of Status of Unvested Restricted Stock Awards Outstanding

	For The Year Ended December 31,
	2019
	Restricted Stock Awards (Amounts in Thousands)			Weighted Average Grant Date Fair Value
Unvested restricted stock awards, beginning of period		149		$	36.10
Awarded		69			68.91
Vested		(66	)		35.58
Forfeited		(3	)		53.54
Unvested restricted stock awards, end of period		149		$	51.10

Segment Information (Tables)

12 Months Ended

Dec. 31, 2019

Segment Reporting [Abstract]

Summary of Segment Information

	For the Year Ended December 31, 2019
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	580,728	$	53,601	$	14,462	$	648,791
Cost of services revenues		432,413		27,203		9,937		469,553
Gross profit		148,315		26,398		4,525		179,238
General and administrative expenses		56,645		12,304		3,199		72,148
Provision for doubtful accounts		242		95		6		343
Segment operating income	$	91,428	$	13,999	$	1,320	$	106,747

	For the Year Ended December 31, 2018
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	490,941	$	18,850	$	6,856	$	516,647
Cost of services revenues		365,264		10,010		4,569		379,843
Gross profit		125,677		8,840		2,287		136,804
General and administrative expenses		44,463		3,737		1,543		49,743
Provision for doubtful accounts		265		5		2		272
Segment operating income	$	80,949	$	5,098	$	742	$	86,789

	For the Year Ended December 31, 2017
	(Amounts in Thousands)
	Personal Care		Hospice		Home Health		Total
Net service revenues	$	425,994	$	—	$	—	$	425,994
Cost of services revenues		310,119		—		—		310,119
Gross profit		115,875		—		—		115,875
General and administrative expenses		35,655		—		—		35,655
Provision for doubtful accounts		9,524		—		—		9,524
Segment operating income	$	70,696	$	—	$	—	$	70,696

	For the Years Ended December 31,
	(Amounts in Thousands)
	2019			2018			2017
Segment reconciliation:
Total segment operating income	$	106,747		$	86,789		$	70,696

Items not allocated at segment level:
Other general and administrative expenses		61,421			55,282			41,247
Depreciation and amortization		10,574			8,642			6,663
Loss (gain) on sale of assets		—			38			(2,467	)
Interest income		(1,523	)		(2,592	)		(66	)
Interest expense		3,105			5,016			4,472
Other income		—			—			(217	)
Income before income taxes	$	33,170		$	20,403		$	21,064

Significant Payors (Tables)

12 Months Ended

Dec. 31, 2019

Significant Payors [Abstract]

Schedule of Revenue by Payor Type

For 2019, 2018 and 2017, our revenue by payor type was as follows:

	Personal Care
	2019					2018 ⁽¹⁾					2017 ⁽¹⁾
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
State, local and other governmental programs	$	303,479		52.2	%	$	285,973		58.2	%	$	273,525		64.2	%
Managed care organizations		239,559		41.3			173,391		35.3			140,993		33.1
Private pay		21,765		3.7			20,003		4.1			8,739		2.1
Commercial insurance		9,204		1.6			6,173		1.3			2,737		0.6
Other		6,721		1.2			5,401		1.1			—		—
Total personal care segment net service revenues	$	580,728		100.0	%	$	490,941		100.0	%	$	425,994		100.0	%

	Hospice
	2019					2018
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	49,649		92.6	%	$	17,652		93.6	%
Managed care organizations		2,768		5.2			1,047		5.6
Other		1,184		2.2			151		0.8
Total hospice segment net service revenues	$	53,601		100.0	%	$	18,850		100.0	%

	Home Health
	2019					2018
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Medicare	$	11,218		77.6	%	$	6,034		88.0	%
Managed care organizations		2,942		20.3			752		11.0
Other		302		2.1			70		1.0
Total home health segment net service revenues	$	14,462		100.0	%	$	6,856		100.0	%

Schedule of Revenue by Geographic Location

	Personal Care
	2019					2018 ⁽¹⁾					2017 ⁽¹⁾
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
Illinois	$	247,524		42.6	%	$	232,518		47.3	%	$	224,257		52.6	%
New York		108,403		18.7			65,117		13.3			58,360		13.7
New Mexico		75,666		13.0			58,914		12.0			37,588		8.8
All other states		149,135		25.7			134,392		27.4			105,789		24.9
Total personal care segment net service revenues	$	580,728		100.0	%	$	490,941		100.0	%	$	425,994		100.0	%

	Hospice
	2019					2018
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	38,790		72.4	%	$	18,850		100.0	%
All other states		14,811		27.6			—		—
Total hospice segment net service revenues	$	53,601		100.0	%	$	18,850		100.0	%

	Home Health
	2019					2018
	Amount (in Thousands)		% of Segment Net Service Revenues			Amount (in Thousands)		% of Segment Net Service Revenues
New Mexico	$	14,462		100.0	%	$	6,856		100.0	%
Total home health segment net service revenues	$	14,462		100.0	%	$	6,856		100.0	%

Unaudited Summarized Quarterly Financial Information (Tables)

12 Months Ended

Dec. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Results of Operations

The following is a summary of the Company’s unaudited quarterly results of operations. See Note 2. Revision of Previously Issued Financial Statements.

	Year Ended December 31, 2019									Year Ended December 31, 2018
	Dec. 31		Sept. 30			Jun. 30		Mar. 31		Dec. 31		Sept. 30		Jun. 30		Mar. 31
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	192,376	$	168,993		$	148,915	$	138,507	$	139,288	$	137,341	$	130,892	$	109,126
Gross profit		57,542		45,176			39,693		36,827		37,429		36,415		35,377		27,583
Operating income from continuing operations		14,530		7,335			7,391		5,496		6,428		5,613		6,547		4,239
Net income from continuing operations		10,737		5,486			5,292		4,296		4,266		3,358		4,052		4,631
(Loss) earnings from discontinued operations		—		(574	)		—		—		126		—		—		—
Net income	$	10,737	$	4,912		$	5,292	$	4,296	$	4,392	$	3,358	$	4,052	$	4,631
Average shares outstanding:
Basic		15,435		13,766			13,044		12,995		12,964		12,179		11,533		11,502
Diluted		15,881		14,203			13,433		13,381		13,381		12,569		11,838		11,696
Income per common share:
Basic
Continuing operations	$	0.70	$	0.40		$	0.41	$	0.33	$	0.33	$	0.28	$	0.35	$	0.40
Discontinued operations		—		(0.04	)		—		—		0.01		—		—		—
Basic net income per share	$	0.70	$	0.36		$	0.41	$	0.33	$	0.34	$	0.28	$	0.35	$	0.40
Diluted net income per share
Continuing operations	$	0.68	$	0.39		$	0.39	$	0.32	$	0.32	$	0.27	$	0.34	$	0.40
Discontinued operations		—		(0.04	)		—		—		0.01		—		—		—
Diluted net income per share	$	0.68	$	0.35		$	0.39	$	0.32	$	0.33	$	0.27	$	0.34	$	0.40

Schedule of Error Corrections and Prior Period Adjustments

Consolidated Balance Sheet as of December 31, 2018 (in thousands):

	As
	Previously					As
	Reported		Revision			Revised
Accounts receivable, net of allowances	$	108,000	$	(9,684	)	$	98,316
Prepaid expenses and other current assets		7,098		194			7,292
Deferred tax assets, net		—		2,196			2,196
Total assets		355,388		(7,294	)		348,094
Deferred tax liabilities, net		494		(494	)		—
Other long-term liabilities		635		242			877
Total liabilities		79,855		(252	)		79,603
Total stockholders’ equity		275,533		(7,042	)		268,491
Total liabilities and stockholders’ equity	$	355,388	$	(7,294	)		348,094

Consolidated Statement of Stockholders’ Equity Opening Balance:

	Common Stock				Additional Paid in Capital		Retained Earnings			Total Stockholders' Equity
	Shares		Amount
Balance at January 1, 2017		11,527	$	12	$	92,253	$	66,653		$	158,918
Revision				—		—		(4,244	)		(4,244	)
Balance at January 1, 2017, as revised		11,527	$	12	$	92,253	$	62,409		$	154,674

Consolidated Statements of Income (in thousands):

	For the Years Ended December 31,
	2018							2017
	As							As
	Previously					As		Previously					As
	Reported		Revision			Revised		Reported		Revision			Revised
Net service revenues	$	518,119	$	(1,472	)	$	516,647	$	425,994	$	—		$	425,994
Gross profit		138,276		(1,472	)		136,804		115,875		—			115,875
Provision for doubtful accounts		272		—			272		8,409		1,115			9,524
Total operating expenses		113,977		—			113,977		89,507		1,115			90,622
Operating income from continuing operations		24,299		(1,472	)		22,827		26,368		(1,115	)		25,253
Income from continuing operations before income taxes		21,875		(1,472	)		20,403		22,179		(1,115	)		21,064
Income tax expense		4,498		(402	)		4,096		8,645		613			9,258
Net income from continuing operations		17,377		(1,070	)		16,307		13,534		(1,728	)		11,806
Net income	$	17,503	$	(1,070	)	$	16,433	$	13,681	$	(1,728	)	$	11,953

Basic income per share from continuing operations		1.44		(0.09	)		1.35		1.18		(0.15	)		1.03
Diluted income per share from continuing operations	$	1.40	$	(0.08	)	$	1.32	$	1.16	$	(0.14	)	$	1.02

Basic income per share		1.45		(0.09	)		1.36		1.19		(0.15	)		1.04
Diluted income per share	$	1.41	$	(0.08	)	$	1.33	$	1.17	$	(0.14	)	$	1.03

Consolidated Statements of Cash Flows (in thousands):

	For the Years Ended December 31,
	2018									2017
	As									As
	Previously						As			Previously						As
	Reported			Revision			Revised			Reported			Revision			Revised
Net income	$	17,503		$	(1,070	)	$	16,433		$	13,681		$	(1,728	)	$	11,953
Provision for doubtful accounts		272			—			272			8,409			1,115			9,524
Deferred income taxes		(43	)		(332	)		(375	)		1,754			716			2,470
Prepaid expenses and other current assets		1,964			(312	)		1,652			(2,364	)		(103	)		(2,467	)
Accrued expenses and other liabilities		(1,107	)		242			(865	)		1,779			—			1,779
Accounts receivable		(2,169	)		1,472			(697	)		19,412			—			19,412
Net cash provided by operating activities	$	33,203		$	—		$	33,203		$	52,771		$	—		$	52,771

	For the Three Months Ended March 31, 2019							For the Three Months Ended March 31, 2018
	Previously reported		Revision			As Revised		Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	139,254	$	(747	)	$	138,507	$	109,476	$	(350	)	$	109,126
Gross profit		37,574		(747	)		36,827		27,933		(350	)		27,583
Operating income from continuing operations		6,243		(747	)		5,496		4,589		(350	)		4,239
Net income from continuing operations		4,862		(566	)		4,296		4,886		(255	)		4,631
Net income		4,862		(566	)		4,296		4,886		(255	)		4,631
Income per common share:
Basic	$	0.37	$	(0.04	)	$	0.33	$	0.42	$	(0.02	)	$	0.40
Diluted	$	0.36	$	(0.04	)	$	0.32	$	0.42	$	(0.02	)	$	0.40

	For the Three Months Ended June 30, 2019							For the Three Months Ended June 30, 2018
	Previously reported		Revision			As Revised		Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	149,692	$	(777	)	$	148,915	$	131,258	$	(366	)	$	130,892
Gross profit		40,470		(777	)		39,693		35,743		(366	)		35,377
Operating income from continuing operations		7,713		(322	)		7,391		6,913		(366	)		6,547
Net income from continuing operations		5,518		(226	)		5,292		4,318		(266	)		4,052
Net income		5,518		(226	)		5,292		4,318		(266	)		4,052
Income per common share:
Basic	$	0.42	$	(0.01	)	$	0.41	$	0.37	$	(0.02	)	$	0.35
Diluted	$	0.41	$	(0.02	)	$	0.39	$	0.36	$	(0.02	)	$	0.34

	For the Three Months Ended September 30, 2019							For the Three Months Ended September 30, 2018
	Previously reported		Revision			As Revised		Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	169,803	$	(810	)	$	168,993	$	137,716	$	(375	)	$	137,341
Gross profit		45,986		(810	)		45,176		36,790		(375	)		36,415
Operating income from continuing operations		7,280		55			7,335		5,988		(375	)		5,613
Net income from continuing operations		5,441		45			5,486		3,631		(273	)		3,358
Net income		4,867		45			4,912		3,631		(273	)		3,358
Income per common share:
Basic	$	0.36	$	—		$	0.36	$	0.29	$	(0.01	)	$	0.28
Diluted	$	0.34	$	0.01		$	0.35	$	0.28	$	(0.01	)	$	0.27

	For the Three Months Ended December 30, 2018
	Previously reported		Revision			As Revised
	(Amounts and Shares in Thousands, Except Per Share Data)
Net service revenues	$	139,669	$	(381	)	$	139,288
Gross profit		37,810		(381	)		37,429
Operating income from continuing operations		6,809		(381	)		6,428
Net income from continuing operations		4,542		(276	)		4,266
Net income		4,668		(276	)		4,392
Income per common share:
Basic	$	0.36	$	(0.02	)	$	0.34
Diluted	$	0.35	$	(0.02	)	$	0.33

Significant Accounting Policies (Narrative) (Details)			3 Months Ended									12 Months Ended
Significant Accounting Policies (Narrative) (Details)	Oct. 01, 2017 USD ($)	Mar. 01, 2013	Dec. 31, 2019 USD ($) shares	Sep. 30, 2019 USD ($)	Jun. 30, 2019 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($) shares	Dec. 30, 2018 USD ($)	Sep. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2019 USD ($) segment item shares	Dec. 31, 2018 USD ($) shares	Dec. 31, 2017 USD ($) shares
Summary Of Significant Accounting Policies [Line Items]
Number of operating segments \| segment												3
Settlement expense in discontinued operation												$ 600,000
Net service revenues			$ 192,376,000	$ 168,993,000	$ 148,915,000	$ 138,507,000	$ 139,288,000	$ 139,288,000	$ 137,341,000	$ 130,892,000	$ 109,126,000	648,791,000	$ 516,647,000	$ 425,994,000
Contract with customer liability			400,000									400,000
Goodwill impairment charge												0	0	0
Goodwill			275,368,000				135,442,000					275,368,000	135,442,000	90,339,000
Impairment of finite-lived intangible assets												0	0	0
Intangibles, net of accumulated amortization			57,079,000				23,784,000					57,079,000	23,784,000
Deductible component of workers' compensation												400,000
Letters of credit secure compensation program			10,000,000.0				10,800,000					10,000,000.0	10,800,000
Accrued workers’ compensation insurance			14,143,000				15,169,000					14,143,000	15,169,000
Workers' compensation insurance recovery receivables			$ 1,989,000				$ 1,692,000					1,989,000	1,692,000
Interest income received												$ 700,000	2,300,000	0
Number of stock incentive plans \| item												1
Stock-based compensation expense												$ 5,800,000	4,100,000	2,500,000
Stock Options [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock-based compensation expense												$ 2,500,000	$ 2,000,000.0	$ 1,100,000
Number of stock options included in calculation \| shares			648,000				683,000					648,000	683,000	479,000
Number of dilutive shares outstanding \| shares												346,000	247,000	101,000
Restricted Stock [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock-based compensation expense												$ 3,300,000	$ 2,100,000	$ 1,400,000
Number of dilutive shares outstanding \| shares												86,000	88,000	52,000
Shares of restricted stock awards included in calculation \| shares												149,000	149,000	143,000
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives												3 years
Minimum [Member] \| Customer and Referral Relationships [Member]
Summary Of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives												5 years
Maximum [Member]
Summary Of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives												25 years
Maximum [Member] \| Customer and Referral Relationships [Member]
Summary Of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives												10 years
Accounting Standards Update 2014-09 [Member]
Summary Of Significant Accounting Policies [Line Items]
Net service revenues													$ (11,000,000.0)
Accounts receivable, allowance for doubtful accounts			$ 1,000,000.0				$ 900,000					$ 1,000,000.0	900,000
Accounting Standards Update 2014-09 [Member] \| Subsequent Changes [Member]
Summary Of Significant Accounting Policies [Line Items]
Net service revenues												100,000	$ 1,500,000
2013 Home Health Business [Member]
Summary Of Significant Accounting Policies [Line Items]
Equity ownership percentage sold in joint venture	10.00%	90.00%
Settlement expense in discontinued operation												$ 600,000
LHC Group, Inc. [Member]
Summary Of Significant Accounting Policies [Line Items]
Equity ownership percentage sold in joint venture	10.00%
Proceeds from the sale of investments in joint ventures	$ 1,300,000
Pre-tax gain from sale of the investments in joint ventures	$ 400,000

Significant Accounting Policies (Estimated Useful Lives of Property and Equipment) (Details)	12 Months Ended
	Dec. 31, 2019
Computer Equipment [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment useful life	3 years
Computer Equipment [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment useful life	5 years
Furniture and Equipment [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment useful life	5 years
Furniture and Equipment [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment useful life	7 years
Transportation Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment useful life	5 years
Computer Software [Member] \| Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment useful life	3 years
Computer Software [Member] \| Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment useful life	10 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Leasehold improvements	Lesser of useful life or lease term

Revision of Previously Issued Financial Statements (Narrative) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Jan. 02, 2017
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Provision for doubtful accounts	$ 343	$ 272	$ 9,524
Accounting Standards Update 2014-09 [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Accounting standard adoption adjustment to revenue		(1,500)
Adjustments [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Deferred tax liabilities, net		(500)
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Deferred tax liabilities, net		(494)
Cumulative effect of adjustments required to correct errors in financial statements years prior to 2017				$ (4,200)
Provision for doubtful accounts			1,115
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Deferred tax liabilities, net		494
Provision for doubtful accounts		272	$ 8,409
As Previously Reported [Member] \| Accounting Standards Update 2014-09 [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Provision for doubtful accounts		$ 11,000

Revision of Previously Issued Financial Statements (Consolidated Balance Sheet) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Accounts receivable, net of allowances	$ 149,680	$ 98,316
Prepaid expenses and other current assets	7,993	7,292
Deferred tax assets, net		2,196
Total assets	636,748	348,094
Other long-term liabilities	163	877
Total liabilities	161,156	79,603
Total stockholders’ equity	475,592	268,491	$ 170,337	$ 154,674
Total liabilities and stockholders’ equity	$ 636,748	348,094
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Accounts receivable, net of allowances		108,000
Prepaid expenses and other current assets		7,098
Total assets		355,388
Deferred tax liabilities, net		494
Other long-term liabilities		635
Total liabilities		79,855
Total stockholders’ equity		275,533		158,918
Total liabilities and stockholders’ equity		355,388
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Accounts receivable, net of allowances		(9,684)
Prepaid expenses and other current assets		194
Deferred tax assets, net		2,196
Total assets		(7,294)
Deferred tax liabilities, net		(494)
Other long-term liabilities		242
Total liabilities		(252)
Total stockholders’ equity		(7,042)		$ (4,244)
Total liabilities and stockholders’ equity		$ (7,294)

Revision of Previously Issued Financial Statements (Cumulative Effect of Adjustments) (Details) - USD ($) shares in Thousands, $ in Thousands	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity	$ 475,592	$ 268,491	$ 170,337	$ 154,674
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity		275,533		158,918
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity		(7,042)		(4,244)
Common Stock [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity	$ 15	$ 13	$ 12	$ 12
Balance, shares	15,617	13,126	11,632	11,527
Common Stock [Member] \| As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity				$ 12
Balance, shares				11,527
Additional Paid-in Capital [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity	$ 359,545	$ 177,683	$ 95,963	$ 92,253
Additional Paid-in Capital [Member] \| As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity				92,253
Retained Earnings [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity	$ 116,032	$ 90,795	$ 74,362	62,409
Retained Earnings [Member] \| As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity				66,653
Retained Earnings [Member] \| Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Total stockholders’ equity				$ (4,244)

Revision of Previously Issued Financial Statements (Consolidated Statements of Income) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended									12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 30, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net service revenues	$ 192,376	$ 168,993	$ 148,915	$ 138,507	$ 139,288	$ 139,288	$ 137,341	$ 130,892	$ 109,126	$ 648,791	$ 516,647	$ 425,994
Gross profit	57,542	45,176	39,693	36,827	37,429	37,429	36,415	35,377	27,583	179,238	136,804	115,875
Provision for doubtful accounts										343	272	9,524
Total operating expenses										144,486	113,977	90,622
Operating income from continuing operations	14,530	7,335	7,391	5,496	6,428	6,428	5,613	6,547	4,239	34,752	22,827	25,253
Income from continuing operations before income taxes										33,170	20,403	21,064
Income tax expense										7,359	4,096	9,258
Net income from continuing operations	10,737	5,486	5,292	4,296	4,266	4,266	3,358	4,052	4,631	25,811	16,307	11,806
Net income	$ 10,737	$ 4,912	$ 5,292	$ 4,296	$ 4,392	$ 4,392	$ 3,358	$ 4,052	$ 4,631	$ 25,237	$ 16,433	$ 11,953
Basic income per share from continuing operations	$ 0.70	$ 0.40	$ 0.41	$ 0.33	$ 0.33		$ 0.28	$ 0.35	$ 0.40	$ 1.87	$ 1.35	$ 1.03
Diluted income per share from continuing operations	0.68	0.39	0.39	0.32	0.32		0.27	0.34	0.40	1.81	1.32	1.02
Basic income per share	0.70	0.36	0.41	0.33	0.34	$ 0.34	0.28	0.35	0.40	1.83	1.36	1.04
Diluted income per share	$ 0.68	$ 0.35	$ 0.39	$ 0.32	$ 0.33	$ 0.33	$ 0.27	$ 0.34	$ 0.40	$ 1.77	$ 1.33	$ 1.03
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net service revenues		$ 169,803	$ 149,692	$ 139,254		$ 139,669	$ 137,716	$ 131,258	$ 109,476		$ 518,119	$ 425,994
Gross profit		45,986	40,470	37,574		37,810	36,790	35,743	27,933		138,276	115,875
Provision for doubtful accounts											272	8,409
Total operating expenses											113,977	89,507
Operating income from continuing operations		7,280	7,713	6,243		6,809	5,988	6,913	4,589		24,299	26,368
Income from continuing operations before income taxes											21,875	22,179
Income tax expense											4,498	8,645
Net income from continuing operations		5,441	5,518	4,862		4,542	3,631	4,318	4,886		17,377	13,534
Net income		$ 4,867	$ 5,518	$ 4,862		$ 4,668	$ 3,631	$ 4,318	$ 4,886		$ 17,503	$ 13,681
Basic income per share from continuing operations											$ 1.44	$ 1.18
Diluted income per share from continuing operations											1.40	1.16
Basic income per share		$ 0.36	$ 0.42	$ 0.37		$ 0.36	$ 0.29	$ 0.37	$ 0.42		1.45	1.19
Diluted income per share		$ 0.34	$ 0.41	$ 0.36		$ 0.35	$ 0.28	$ 0.36	$ 0.42		$ 1.41	$ 1.17
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net service revenues		$ (810)	$ (777)	$ (747)		$ (381)	$ (375)	$ (366)	$ (350)		$ (1,472)
Gross profit		(810)	(777)	(747)		(381)	(375)	(366)	(350)		(1,472)
Provision for doubtful accounts												$ 1,115
Total operating expenses												1,115
Operating income from continuing operations		55	(322)	(747)		(381)	(375)	(366)	(350)		(1,472)	(1,115)
Income from continuing operations before income taxes											(1,472)	(1,115)
Income tax expense											(402)	613
Net income from continuing operations		45	(226)	(566)		(276)	(273)	(266)	(255)		(1,070)	(1,728)
Net income		$ 45	$ (226)	$ (566)		$ (276)	$ (273)	$ (266)	$ (255)		$ (1,070)	$ (1,728)
Basic income per share from continuing operations											$ (0.09)	$ (0.15)
Diluted income per share from continuing operations											(0.08)	(0.14)
Basic income per share			$ (0.01)	$ (0.04)		$ (0.02)	$ (0.01)	$ (0.02)	$ (0.02)		(0.09)	(0.15)
Diluted income per share		$ 0.01	$ (0.02)	$ (0.04)		$ (0.02)	$ (0.01)	$ (0.02)	$ (0.02)		$ (0.08)	$ (0.14)

Revision of Previously Issued Financial Statements (Consolidated Statements of of Cash Flows) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income	$ 25,237	$ 16,433	$ 11,953
Provision for doubtful accounts	343	272	9,524
Deferred income taxes	(1,063)	(375)	2,470
Prepaid expenses and other current assets	(792)	1,652	(2,467)
Accrued expenses and other liabilities	4,078	(865)	1,779
Accounts receivable	(37,478)	(697)	19,412
Net cash provided by operating activities	$ 12,019	33,203	52,771
As Previously Reported [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income		17,503	13,681
Provision for doubtful accounts		272	8,409
Deferred income taxes		(43)	1,754
Prepaid expenses and other current assets		1,964	(2,364)
Accrued expenses and other liabilities		(1,107)	1,779
Accounts receivable		(2,169)	19,412
Net cash provided by operating activities		33,203	52,771
Revision [Member]
Error Corrections And Prior Period Adjustments Restatement [Line Items]
Net income		(1,070)	(1,728)
Provision for doubtful accounts			1,115
Deferred income taxes		(332)	716
Prepaid expenses and other current assets		(312)	$ (103)
Accrued expenses and other liabilities		242
Accounts receivable		$ 1,472

Leases (Narrative) (Details)	12 Months Ended
Leases (Narrative) (Details)	Dec. 31, 2019
Lessee Lease [Line Items]
Operating lease expiration dates	expiration dates through 2029
Minimum [Member]
Lessee Lease [Line Items]
Leases termination and renewal option	1 year
Maximum [Member]
Lessee Lease [Line Items]
Leases termination and renewal option	5 years

Leases (Amounts Reported in Condensed Consolidated Balance Sheets for Operating Leases) (Details) $ in Thousands	Dec. 31, 2019 USD ($)
Leases [Abstract]
Operating lease assets, net	$ 21,111
Short-term operating lease liabilities (in accrued expenses)	$ 7,234
Operating lease,liability ,current, statement of financial position [Extensible List]	us-gaap:AccruedLiabilitiesCurrent
Long-term operating lease liabilities	$ 14,301
Total operating lease liabilities	$ 21,535

Leases (Components of Lease Cost Reported in General and Administrative Expenses in Condensed Consolidated Statements of Income) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019 USD ($)
Leases [Abstract]
Operating lease costs	$ 7,219
Short-term lease costs	585
Total lease cost	$ 7,804

Leases (Schedule of Weighted Average Remaining Lease Terms and Discount Rates) (Details)	Dec. 31, 2019
Leases [Abstract]
Weighted average remaining lease term	3 years 5 months 1 day
Weighted average discount rate	5.14%

Leases (Summary of Remaining Operating Lease Payments) (Details) $ in Thousands	Dec. 31, 2019 USD ($)
Leases [Abstract]
2020	$ 7,975
2021	6,935
2022	4,331
2023	2,526
2024	1,437
Thereafter	389
Total future minimum rental commitments	23,593
Less: Imputed interest	(2,058)
Total lease liabilities	$ 21,535

Leases (Summary of Future Minimum Operating Lease Payments) (Details) $ in Thousands	Dec. 31, 2018 USD ($)
Leases [Abstract]
2019	$ 6,374
2020	4,820
2021	3,460
2022	2,377
2023	2,130
Thereafter	1,382
Total future minimum rental commitments	$ 20,543

Leases (Supplemental Cash Flows Information) (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2019 USD ($)
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 7,574
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$ 10,299

Public Offering (Narrative) (Details) - USD ($) $ / shares in Units, $ in Thousands					12 Months Ended
	Oct. 01, 2019	Sep. 09, 2019	Aug. 22, 2018	Aug. 20, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Class Of Stock [Line Items]
Common stock, par value					$ 0.001	$ 0.001
Proceeds from issuance of common stock, net of issuance costs					$ 172,945	$ 76,618
Business acquisition purchase price					184,076	62,440	$ 24,354
Increase to additional paid in capital from public offering					$ 172,945	76,618
Repayment of credit facility							$ 30,000
Issuance costs						$ 5,400
Term Loan [Member] \| Credit Facility [Member]
Class Of Stock [Line Items]
Repayment of credit facility			$ 102,600
Hospice Partners of America, LLC [Member]
Class Of Stock [Line Items]
Business acquisition purchase price	$ 130,000
Common Stock [Member]
Class Of Stock [Line Items]
Shares issued during period		2,300,000		2,100,000	2,300,000	1,390,000
Common stock, par value		$ 0.001		$ 0.001
Public offering price, per share		$ 79.50
Proceeds from issuance of common stock, net of issuance costs		$ 172,900
Underwriting discounts and estimated offering expenses		$ 9,900
Increase to additional paid in capital from public offering					$ 2	$ 1
Purchase price per share				$ 59.00
Additional Paid-in Capital [Member]
Class Of Stock [Line Items]
Increase to additional paid in capital from public offering					$ 172,943	$ 76,617
Over-Allotment Option [Member] \| Common Stock [Member]
Class Of Stock [Line Items]
Shares issued during period		300,000	315,000
Proceeds from issuance of common stock, net of issuance costs			$ 17,500
Primary Shares [Member] \| Common Stock [Member]
Class Of Stock [Line Items]
Shares issued during period				1,075,267
Proceeds from issuance of common stock, net of issuance costs				$ 59,100
Secondary Shares [Member] \| Common Stock [Member]
Class Of Stock [Line Items]
Shares issued during period				1,024,733

Acquisitions (Narrative) (Details)									1 Months Ended	3 Months Ended									12 Months Ended
Acquisitions (Narrative) (Details)	Oct. 01, 2019 USD ($) location	Aug. 01, 2019 USD ($)	Jun. 01, 2019 USD ($)	May 01, 2018 USD ($)	Apr. 01, 2018 USD ($)	Jan. 01, 2018 USD ($)	Oct. 01, 2017 USD ($)	Aug. 01, 2017 USD ($) item	Sep. 30, 2018 USD ($)	Dec. 31, 2019 USD ($)	Sep. 30, 2019 USD ($)	Jun. 30, 2019 USD ($)	Mar. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 30, 2018 USD ($)	Sep. 30, 2018 USD ($)	Jun. 30, 2018 USD ($)	Mar. 31, 2018 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)
Business Acquisition [Line Items]
Total purchase price for business acquisition																			$ 184,076,000	$ 62,440,000	$ 24,354,000
Net service revenues										$ 192,376,000	$ 168,993,000	$ 148,915,000	$ 138,507,000	$ 139,288,000	$ 139,288,000	$ 137,341,000	$ 130,892,000	$ 109,126,000	648,791,000	516,647,000	425,994,000
Operating income (loss) from continuing operations																			33,170,000	20,403,000	21,064,000
Goodwill										$ 275,368,000				$ 135,442,000					$ 275,368,000	135,442,000	90,339,000
Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			3 years
Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			25 years
State Licenses [Member]
Business Acquisition [Line Items]
Identifiable intangible assets acquired			$ 10,700,000
Customer Relationships [Member]
Business Acquisition [Line Items]
Identifiable intangible assets acquired			4,700,000
Hospice Partners [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition	$ 135,600,000
Number of locations \| location	21
Acquisition related costs																			$ 1,600,000
Integration costs																			600,000
Net service revenues																			14,800,000
Operating income (loss) from continuing operations																			$ 2,300,000
Goodwill	$ 112,484,000
Hospice Partners [Member] \| Trade Names [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			15 years
Identifiable intangible assets acquired	9,500,000
Hospice Partners [Member] \| Non-competition Agreements [Member]
Business Acquisition [Line Items]
Identifiable intangible assets acquired	$ 2,500,000																		$ 2,500,000
Hospice Partners [Member] \| Non-competition Agreements [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives	3 years
Hospice Partners [Member] \| Non-competition Agreements [Member] \| Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives	5 years
Hospice Partners [Member] \| State Licenses [Member]
Business Acquisition [Line Items]
Indefinite lived intangible assets acquired	$ 6,100,000
Alliance Home Health Care [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition		$ 23,500,000
Acquisition related costs																			400,000
Integration costs																			400,000
Goodwill		16,646,000
Alliance Home Health Care [Member] \| New York [Member]
Business Acquisition [Line Items]
Net service revenues																			8,800,000
Operating income (loss) from continuing operations																			$ 2,100,000
Alliance Home Health Care [Member] \| State Licenses [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			10 years
Identifiable intangible assets acquired		1,100,000																	$ 1,100,000
Indefinite lived intangible assets acquired		$ 4,300,000
VIP Health Care Services [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition			29,900,000
Acquisition related costs																			300,000
Integration costs																			500,000
Goodwill			$ 10,550,000
VIP Health Care Services [Member] \| New York [Member]
Business Acquisition [Line Items]
Net service revenues																			30,000,000.0
Operating income (loss) from continuing operations																			$ (200,000)
VIP Health Care Services [Member] \| State Licenses [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			6 years
Identifiable intangible assets acquired																			$ 10,700,000
VIP Health Care Services [Member] \| Customer Relationships [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			8 years
Identifiable intangible assets acquired																			$ 4,700,000
Ambercare Corporation [Member]
Business Acquisition [Line Items]
Goodwill				$ 28,831,000
Ambercare Corporation [Member] \| New Mexico [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition				12,000,000.0
Acquisition related costs																				800,000
Integration costs																			$ 200,000	1,600,000
Net service revenues																				36,700,000
Operating income (loss) from continuing operations																				7,100,000
Total purchase price for business acquisition				$ 39,600,000
Ambercare Corporation [Member] \| Trade Name and Customer Relationships [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			3 years
Ambercare Corporation [Member] \| Trade Name and Customer Relationships [Member] \| Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			15 years
Arcadia Home Care And Staffing [Member]
Business Acquisition [Line Items]
Acquisition related costs																				800,000	400,000
Integration costs																			$ 200,000	1,100,000
Net service revenues																				32,700,000
Operating income (loss) from continuing operations																				4,700,000
Total purchase price for business acquisition					$ 18,900,000
Goodwill					$ 13,072,000
Arcadia Home Care And Staffing [Member] \| Trade Names, Customer Relationships and State Licenses [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			7 years
Arcadia Home Care And Staffing [Member] \| Trade Names, Customer Relationships and State Licenses [Member] \| Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			15 years
Affiliate Branches of Arcadia [Member]
Business Acquisition [Line Items]
Acquisitions of business cash consideration									$ 600,000
Goodwill									$ 600,000							$ 600,000
Lifestyle Options, Inc. [Member]
Business Acquisition [Line Items]
Goodwill						$ 2,751,000
Lifestyle Options, Inc. [Member] \| Illinois [Member]
Business Acquisition [Line Items]
Net service revenues																				5,800,000
Operating income (loss) from continuing operations																				500,000
Total purchase price for business acquisition						4,100,000
Acquisitions of business cash consideration						3,300,000
Business acquisition, contingent earn-out obligation						$ 800,000
Contingent consideration, remeasured																				0
Lifestyle Options, Inc. [Member] \| Trade Name and Customer Relationships [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			10 years
Lifestyle Options, Inc. [Member] \| Trade Name and Customer Relationships [Member] \| Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			15 years
Sun Cities Homecare [Member]
Business Acquisition [Line Items]
Goodwill							$ 1,089,000
Sun Cities Homecare [Member] \| Arizona [Member]
Business Acquisition [Line Items]
Total purchase price for business acquisition							$ 2,300,000
Acquisition related costs																				100,000	100,000
Net service revenues																					700,000
Operating income (loss) from continuing operations																					100,000
Sun Cities Homecare [Member] \| Trade Name and Customer Relationships [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			7 years
Sun Cities Homecare [Member] \| Trade Name and Customer Relationships [Member] \| Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			15 years
Options Home Care [Member]
Business Acquisition [Line Items]
Goodwill								$ 16,671,000
Options Home Care [Member] \| New Mexico [Member]
Business Acquisition [Line Items]
Acquisition related costs																				$ 100,000	700,000
Integration costs																					100,000
Net service revenues																					8,000,000.0
Operating income (loss) from continuing operations																					$ 1,500,000
Total purchase price for business acquisition								$ 22,600,000
Options Home Care [Member] \| Minimum [Member] \| New Mexico [Member]
Business Acquisition [Line Items]
Number of counties under personal care services \| item								20
Options Home Care [Member] \| Trade Name and Customer Relationships [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			3 years
Options Home Care [Member] \| Trade Name and Customer Relationships [Member] \| Maximum [Member]
Business Acquisition [Line Items]
Intangible assets, estimated useful lives																			10 years

Acquisitions (Schedule of Fair Values of Assets and Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Oct. 01, 2019	Aug. 01, 2019	Jun. 01, 2019	Dec. 31, 2018	May 01, 2018	Apr. 01, 2018	Jan. 01, 2018	Dec. 31, 2017	Oct. 01, 2017	Aug. 01, 2017
Business Acquisition [Line Items]
Goodwill	$ 275,368				$ 135,442				$ 90,339
Hospice Partners [Member]
Business Acquisition [Line Items]
Goodwill		$ 112,484
Identifiable intangible assets		18,090
Cash		5,705
Property and equipment		164
Accounts receivable		6,506
Operating lease assets, net		2,518
Other assets		632
Deferred tax liability		(1,540)
Accounts payable		(1,618)
Accrued expenses		(4,650)
Accrued payroll		(1,108)
Long-term operating lease liabilities		(1,615)
Total purchase price		$ 135,568
Alliance Home Health Care [Member]
Business Acquisition [Line Items]
Goodwill			$ 16,646
Identifiable intangible assets			5,422
Cash			260
Accounts receivable			1,665
Accounts payable			(299)
Other liabilities			(236)
Total purchase price			$ 23,458
VIP Health Care Services [Member]
Business Acquisition [Line Items]
Goodwill				$ 10,550
Identifiable intangible assets				15,370
Cash				110
Property and equipment				27
Accounts receivable				6,058
Operating lease assets, net				2,278
Other assets				30
Accounts payable				(462)
Accrued expenses				(770)
Accrued payroll				(1,742)
Long-term operating lease liabilities				(1,531)
Total purchase price				$ 29,918
Ambercare Corporation [Member]
Business Acquisition [Line Items]
Goodwill						$ 28,831
Identifiable intangible assets						9,944
Cash						12,028
Property and equipment						154
Accounts receivable						6,512
Other assets						442
Deferred tax liability						(2,138)
Financing lease						(75)
Accounts payable						(3)
Accrued expenses						(4,073)
Total purchase price						$ 51,622
Arcadia Home Care And Staffing [Member]
Business Acquisition [Line Items]
Goodwill							$ 13,072
Identifiable intangible assets							2,264
Property and equipment							155
Accounts receivable							5,317
Other assets							92
Accounts payable							(508)
Accrued expenses							(1,540)
Total purchase price							$ 18,852
Lifestyle Options, Inc. [Member]
Business Acquisition [Line Items]
Goodwill								$ 2,751
Identifiable intangible assets								1,152
Property and equipment								18
Accounts receivable								573
Other assets								32
Accounts payable								(105)
Accrued expenses								(291)
Total purchase price								$ 4,130
Sun Cities Homecare [Member]
Business Acquisition [Line Items]
Goodwill										$ 1,089
Identifiable intangible assets										682
Cash										321
Accounts receivable										254
Other assets										10
Accounts payable										(14)
Accrued expenses										(86)
Total purchase price										$ 2,256
Options Home Care [Member]
Business Acquisition [Line Items]
Goodwill											$ 16,671
Identifiable intangible assets											5,324
Cash											205
Accounts receivable											1,084
Other assets											41
Accrued liabilities											(701)
Total purchase price											$ 22,624

Acquisitions (Unaudited Pro Forma Condensed Consolidated Income Statement Information) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Hospice Partners, Alliance and VIP [Member]
Business Acquisition [Line Items]
Net service revenues	$ 726,727
Operating income from continuing operations	46,571
Net income from continuing operations	$ 35,748
Basic income per share	$ 2.59
Diluted income per share	$ 2.51
Ambercare, Arcadia, LifeStyle, Sun Cities and Options [Member]
Business Acquisition [Line Items]
Net service revenues		$ 550,326
Operating income from continuing operations		36,985
Net income from continuing operations		$ 24,346
Basic income per share		$ 2.02
Diluted income per share		$ 1.97
Sun Cities and Options Home Care [Member]
Business Acquisition [Line Items]
Net service revenues			$ 441,858
Operating income from continuing operations			28,103
Net income from continuing operations			$ 15,010
Basic income per share			$ 1.31
Diluted income per share			$ 1.29

Property and Equipment (Schedule of Property and Equipment) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 22,183	$ 16,759
Less: accumulated depreciation and amortization	(10,027)	(6,101)
Property and equipment, net	12,156	10,658
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	5,304	3,768
Furniture and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,410	3,161
Transportation Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	157	156
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	3,749	2,962
Computer Software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 9,563	$ 6,712

Property and Equipment (Narrative) (Details) $ in Thousands	12 Months Ended
Property and Equipment (Narrative) (Details) $ in Thousands	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($) item
Property, Plant and Equipment [Line Items]
Property and equipment	$ 22,183	$ 16,759
Depreciation and amortization	10,574	8,642	$ 6,663
Gain on sale of adult day services centers	0	(38)	2,467
Internally Developed Software [Member]
Property, Plant and Equipment [Line Items]
Property and equipment	1,600	1,300
Depreciation and amortization	$ 4,000	$ 2,500	$ 2,000
Illinois [Member]
Property, Plant and Equipment [Line Items]
Number of adult day centers sold \| item			3
Proceeds from sale of adult day service centers			$ 2,400
Gain on sale of adult day services centers			$ 2,100

Goodwill and Intangible Assets (Narrative) (Details) - USD ($)				12 Months Ended
	Oct. 01, 2019	Aug. 01, 2019	Jun. 01, 2019	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Goodwill [Line Items]
Goodwill impairment charge				$ 0	$ 0	$ 0
Goodwill				275,368,000	135,442,000	90,339,000
Amortization expense				$ 6,600,000	6,200,000	4,700,000
Weighted average remaining useful lives of identifiable intangible assets				9 years
Minimum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				3 years
Maximum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				25 years
Customer and Referral Relationships [Member] \| Minimum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				5 years
Customer and Referral Relationships [Member] \| Maximum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				10 years
State Licenses [Member]
Goodwill [Line Items]
Finite-lived intangible assets related to acquisition			$ 10,700,000
Customer Relationships [Member]
Goodwill [Line Items]
Finite-lived intangible assets related to acquisition			4,700,000
Personal Care [Member]
Goodwill [Line Items]
Goodwill				$ 126,577,000	112,377,000	$ 90,339,000
Hospice [Member]
Goodwill [Line Items]
Goodwill				146,983,000	22,200,000
Home Health [Member]
Goodwill [Line Items]
Goodwill				$ 1,808,000	$ 865,000
VIP Health Care Services [Member]
Goodwill [Line Items]
Goodwill			10,550,000
VIP Health Care Services [Member] \| State Licenses [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				6 years
Finite-lived intangible assets related to acquisition				$ 10,700,000
VIP Health Care Services [Member] \| Customer Relationships [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				8 years
Finite-lived intangible assets related to acquisition				$ 4,700,000
VIP Health Care Services [Member] \| Personal Care [Member]
Goodwill [Line Items]
Goodwill			$ 10,600,000
Alliance Home Health Care [Member]
Goodwill [Line Items]
Goodwill		$ 16,646,000
Alliance Home Health Care [Member] \| State Licenses [Member]
Goodwill [Line Items]
Indefinite lived intangible assets acquired				$ 4,300,000
Alliance Home Health Care [Member] \| State Licenses [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives				10 years
Finite-lived intangible assets related to acquisition		1,100,000		$ 1,100,000
Indefinite lived intangible assets acquired		4,300,000
Alliance Home Health Care [Member] \| Personal Care [Member]
Goodwill [Line Items]
Goodwill		3,400,000
Alliance Home Health Care [Member] \| Hospice [Member]
Goodwill [Line Items]
Goodwill		12,300,000
Alliance Home Health Care [Member] \| Home Health [Member]
Goodwill [Line Items]
Goodwill		$ 900,000
Hospice Partners [Member]
Goodwill [Line Items]
Goodwill	$ 112,484,000
Hospice Partners [Member] \| State Licenses [Member]
Goodwill [Line Items]
Indefinite lived intangible assets acquired				6,100,000
Hospice Partners [Member] \| State Licenses [Member]
Goodwill [Line Items]
Indefinite lived intangible assets acquired	6,100,000
Hospice Partners [Member] \| Trade Names And Trademarks [Member]
Goodwill [Line Items]
Finite-lived intangible assets related to acquisition				9,500,000
Hospice Partners [Member] \| Non-competition Agreements [Member]
Goodwill [Line Items]
Finite-lived intangible assets related to acquisition	$ 2,500,000			2,500,000
Hospice Partners [Member] \| Non-competition Agreements [Member] \| Minimum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives	3 years
Hospice Partners [Member] \| Non-competition Agreements [Member] \| Maximum [Member]
Goodwill [Line Items]
Intangible assets, estimated useful lives	5 years
Hospice Partners [Member] \| Hospice [Member]
Goodwill [Line Items]
Goodwill	$ 112,500,000
Other Immaterial Acquisitions [Member] \| Personal Care [Member]
Goodwill [Line Items]
Goodwill				$ 400,000

Goodwill and Intangible Assets (Summary of Goodwill and Related Adjustments) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Goodwill [Line Items]
Goodwill, at Beginning of Period	$ 135,442	$ 90,339
Additions for acquisitions	140,059	45,200
Adjustments to previously recorded goodwill	(133)	(97)
Goodwill, at End of Period	275,368	135,442
Personal Care [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	112,377	90,339
Additions for acquisitions	14,368	22,135
Adjustments to previously recorded goodwill	(168)	(97)
Goodwill, at End of Period	126,577	112,377
Hospice [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	22,200
Additions for acquisitions	124,750	22,200
Adjustments to previously recorded goodwill	33
Goodwill, at End of Period	146,983	22,200
Home Health [Member]
Goodwill [Line Items]
Goodwill, at Beginning of Period	865
Additions for acquisitions	941	865
Adjustments to previously recorded goodwill	2
Goodwill, at End of Period	$ 1,808	$ 865

Goodwill and Intangible Assets (Schedule of Carrying Amount and Accumulated Amortization of Intangible Asset) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Finite Lived Intangible Assets [Line Items]
Intangible assets with indefinite lives	$ 13,306	$ 2,871
Intangible assets subject to amortization:
Gross carrying amount	95,739	66,303
Accumulated amortization	(51,966)	(45,390)
Intangible assets subject to amortization, net	43,773	20,913
Net balance at end of period	57,079	23,784
Customer And Referral Relationships [Member]
Intangible assets subject to amortization:
Gross carrying amount	48,028	42,356
Accumulated amortization	(35,665)	(32,752)
Intangible assets subject to amortization, net	12,363	9,604
Net balance at end of period	12,363	9,604
Trade Names And Trademarks [Member]
Intangible assets subject to amortization:
Gross carrying amount	31,036	21,551
Accumulated amortization	(12,941)	(10,638)
Intangible assets subject to amortization, net	18,095	10,913
Net balance at end of period	18,095	10,913
Non-competition Agreements [Member]
Intangible assets subject to amortization:
Gross carrying amount	4,655	2,155
Accumulated amortization	(2,234)	(1,981)
Intangible assets subject to amortization, net	2,421	174
Net balance at end of period	2,421	174
State Licenses [Member]
Finite Lived Intangible Assets [Line Items]
Intangible assets with indefinite lives	13,306	2,871
Intangible assets subject to amortization:
Gross carrying amount	12,020	241
Accumulated amortization	(1,126)	(19)
Intangible assets subject to amortization, net	10,894	222
Net balance at end of period	$ 24,200	$ 3,093

Goodwill And Intangible Assets (Schedule of Future Amortization of Intangible Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2020	$ 6,935
2021	6,440
2022	5,419
2023	4,936
2024	4,692
Thereafter	15,351
Intangible assets subject to amortization, net	$ 43,773	$ 20,913

Details of Certain Balance Sheet Accounts (Schedule of Prepaid Expenses and Other Current Assets) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Details Of Certain Balance Sheet Accounts [Abstract]
Prepaid workers’ compensation and liability insurance	$ 2,040	$ 1,840
Workers’ compensation insurance receivable	1,989	1,692
Health insurance receivable	1,567	564
Other	2,397	3,196
Total prepaid expenses and other current assets	$ 7,993	$ 7,292

Details of Certain Balance Sheet Accounts (Schedule of Accrued Expenses) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Details Of Certain Balance Sheet Accounts [Abstract]
Current portion of operating lease liabilities	$ 7,234
Accrued health insurance	4,140	$ 3,926
Accrued professional fees	2,517	2,260
Accrued payroll taxes	1,843	769
Other	6,695	4,631
Total accrued expenses	$ 22,429	$ 11,586

Long-Term Debt (Schedule of Long-Term Debt) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Financing leases	$ 21	$ 81
Less unamortized issuance costs	(2,452)	(2,797)
Total	59,892	17,284
Less current maturities	(728)	(62)
Long-term debt	59,164	17,222
Revolving Credit Loan [Member] \| Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt gross	43,458	$ 20,000
Term Loan [Member] \| Senior Secured Credit Facility [Member]
Debt Instrument [Line Items]
Long-term debt gross	$ 18,865

Long-Term Debt (Narrative) (Details) - USD ($)				1 Months Ended		12 Months Ended
Long-Term Debt (Narrative) (Details) - USD ($)	Sep. 12, 2019	Aug. 01, 2019	Jun. 01, 2019	Oct. 31, 2018	Oct. 30, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	May 08, 2017
Debt Instrument [Line Items]
Debt issuance costs						$ 2,452,000	$ 2,797,000
Repayment of credit facility								$ 30,000,000
Cash paid for interest						2,320,000	4,339,000	$ 2,261,000
Credit Agreement [Member] \| Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available				$ 269,600,000		$ 191,400,000
Debt instrument, maturity date						May 08, 2023
Debt instrument total net leverage ratio					4.25%
Debt issuance costs				900,000
Letters of credit outstanding amount						$ 10,000,000.0
Credit Agreement [Member] \| Capital One, National Association [Member] \| Delayed Draw Term Loan [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available				$ 19,600,000
Proceeds from line of credit							60,400,000
Credit Agreement [Member] \| Capital One, National Association [Member] \| Delayed Draw Term Loan [Member] \| Alliance Home Health Care [Member]
Debt Instrument [Line Items]
Proceeds from line of credit		$ 23,500,000
Credit Agreement [Member] \| Capital One, National Association [Member] \| Revolving Credit Loan [Member] \| VIP Health Care Services [Member]
Debt Instrument [Line Items]
Proceeds from line of credit			$ 19,600,000
Credit Agreement [Member] \| Capital One, National Association [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Line of credit outstanding amount						$ 18,900,000
Debt instrument stated interest rate						3.45%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument total net leverage ratio				3.75%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Federal Funds Rate [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin				0.50%
Credit Agreement [Member] \| Capital One, National Association [Member] \| London Interbank Offered Rate (LIBOR)
Debt Instrument [Line Items]
Debt instrument variable interest rate margin				1.00%
Credit Agreement [Member] \| Capital One, National Association [Member] \| London Interbank Offered Rate (LIBOR) \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin				0.00%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Senior Leverage Ratio \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin				0.75%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Senior Leverage Ratio \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin				1.50%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Leverage Ratio [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin				1.75%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Based On Applicable Leverage Ratio [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Debt instrument variable interest rate margin				2.50%
Credit Agreement [Member] \| Capital One, National Association [Member] \| Restriction on Dividends [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Aggregate amount of dividends and distributions						$ 7,500,000
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available	$ 300,000,000.0			$ 250,000,000.0			137,400,000
Increase in credit facility	50,000,000.0
Debt issuance costs	$ 400,000
Line of credit outstanding amount						$ 43,400,000	$ 20,000,000.0
Debt instrument stated interest rate						3.44%	4.35%
Letters of credit outstanding amount							$ 10,800,000
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Debt instrument stated interest rate						3.45%
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility						0.20%
Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Fee charged on unused portion of revolving credit facility						0.35%
Existing Credit Agreement [Member]
Debt Instrument [Line Items]
Repayment of credit facility				102,600,000
Cash paid for interest				$ 500,000
Existing Credit Agreement [Member] \| Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available									$ 250,000,000.0
Existing Credit Agreement [Member] \| Capital One, National Association [Member] \| Delayed Draw Term Loan [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available									80,000,000.0
Existing Credit Agreement [Member] \| Capital One, National Association [Member] \| Term Loan [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available									45,000,000.0
Existing Credit Agreement [Member] \| Revolving Credit Loan [Member] \| Capital One, National Association [Member]
Debt Instrument [Line Items]
Maximum aggregate loan amount available									$ 125,000,000.0

Income Taxes (Current and Deferred Federal and State Income Tax Provision from Continuing Operations) (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Current
Federal	$ 5,876	$ 2,883	$ 5,828
State	2,442	1,562	1,078
Deferred
Federal	(734)	(265)	2,447
State	(225)	(84)	(95)
Provision for income taxes	$ 7,359	$ 4,096	$ 9,258

Income Taxes (Deferred Tax Assets And Liabilities) (Details) - USD ($) $ in Thousands	Dec. 31, 2019	Dec. 31, 2018
Income Tax Expense Benefit Continuing Operations Income Tax Reconciliation [Abstract]
Deferred Tax Assets, Accounts receivable allowances	$ 9,256	$ 6,761
Deferred Tax Assets, Accrued compensation	2,765	2,135
Deferred Tax Assets, Accrued workers' compensation	3,327	3,677
Deferred Tax Assets, Transactions Costs	1,311	1,020
Deferred Tax Assets, Restructuring costs	135	160
Deferred Tax Assets, Stock-based compensation	793	576
Deferred Tax Assets, Operating lease liabilities	5,896	170
Deferred Tax Assets, Other	584	279
Total long-term deferred tax assets	24,067	14,778
Deferred Tax Liabilities, Goodwill and intangible assets	(15,079)	(11,048)
Deferred Tax Liabilities, Property and equipment	(1,037)	(903)
Deferred Tax Liabilities, Prepaid insurance	(534)	(508)
Deferred Tax Liabilities, Operating lease assets, net	(5,606)
Deferred Tax Liabilities, Other	(164)	(123)
Total long-term deferred tax liabilities	(22,420)	(12,582)
Total net deferred tax assets (liabilities)	$ 1,647	$ 2,196

Income Taxes (Narrative) (Details)	12 Months Ended
Income Taxes (Narrative) (Details)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Statutory federal tax rate	21.00%	21.00%	35.00%
Effective income tax rate	22.20%	20.10%	44.00%
U.S Federal authorities [Member] \| Minimum [Member]
Tax year open for examination	2016
U.S Federal authorities [Member] \| Maximum [Member]
Tax year open for examination	2018
State authorities [Member] \| Minimum [Member]
Tax year open for examination	2014
State authorities [Member] \| Maximum [Member]
Tax year open for examination	2018

Income Taxes (Reconciliation of Statutory Federal Tax Rate) (Details)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Components Of Income Tax Expense Benefit Continuing Operations [Abstract]
Federal income tax at statutory rate	21.00%	21.00%	35.00%
State and local taxes, net of federal benefit	6.40%	6.30%	5.10%
Jobs tax credits, net	(8.30%)	(10.70%)	(6.50%)
162(m) disallowance for executive compensation	7.50%	4.50%	1.40%
Nondeductible permanent items	0.70%	2.20%	0.40%
Nondeductible penalties	1.30%
2017 Tax Reform Act			9.30%
Excess tax benefit	(6.70%)	(2.70%)	(0.60%)
Other	0.30%	(0.50%)	(0.10%)
Effective income tax rate	22.20%	20.10%	44.00%

Stock Options And Restricted Stock Awards (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense	$ 5.8	$ 4.1	$ 2.5
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense	2.5	2.0	1.1
Unrecognized compensation cost	$ 4.9
Unrecognized compensation cost recognition period	1 year 9 months 18 days
Intrinsic value on vested stock options	$ 16.7
Intrinsic value on outstanding stock options	$ 22.0
Share-based compensation number of shares vested	235,923
Share-based compensation number of shares unvested	411,976
Intrinsic value on exercised stock options	$ 7.3	1.8	0.5
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option compensation expense	3.3	$ 2.1	$ 1.4
Unrecognized compensation cost	$ 5.0
Unrecognized compensation cost recognition period	1 year 7 months 6 days
Fair market value of vested restricted stock awards	$ 4.2
2017 Omnibus Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum shares of stock awards authorized for issuance	1,182,270
Share-based compensation number of shares available for grant	700,000
2017 Omnibus Incentive Plan [Member] \| Stock options or stock appreciation rights "SARs" [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum shares of stock awards authorized for issuance	500,000
2017 Omnibus Incentive Plan [Member] \| Awards denominated in shares of common stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum shares of stock awards authorized for issuance	300,000
2017 Omnibus Incentive Plan [Member] \| Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award, expiration period	10 years
Exercise prices of stock options outstanding, lower range limit	$ 4.62
Exercise prices of stock options outstanding, upper range limit	$ 87.80
2017 Omnibus Incentive Plan [Member] \| Stock Options [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment vesting period	3 years
2017 Omnibus Incentive Plan [Member] \| Stock Options [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment vesting period	4 years
2017 Omnibus Incentive Plan [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment award, expiration period	10 years
2017 Omnibus Incentive Plan [Member] \| Restricted Stock [Member] \| Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment vesting period	1 year
2017 Omnibus Incentive Plan [Member] \| Restricted Stock [Member] \| Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment vesting period	4 years

Stock Options And Restricted Stock Awards (Summary of Stock Option Activity and Weighted Average Exercise Price) (Details) - Stock Options [Member] shares in Thousands	12 Months Ended
	Dec. 31, 2019 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, Outstanding, beginning of period shares \| shares	683
Options, Granted shares \| shares	92
Options, Exercised shares \| shares	(126)
Options, Forfeited/Cancelled shares \| shares	(1)
Options, Outstanding, end of period shares \| shares	648
Weighted Average Exercise Price, Outstanding, beginning of period \| $ / shares	$ 29.60
Weighted Average Exercise Price, Granted \| $ / shares	79.21
Weighted Average Exercise Price, Exercised \| $ / shares	25.11
Weighted Average Exercise Price, Forfeited/Cancelled \| $ / shares	52.50
Weighted Average Exercise Price, Outstanding, end of period \| $ / shares	$ 37.43

Stock Options And Restricted Stock Awards (Weighted-Average Estimated Fair Value of Employee Stock Options Granted) (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average fair value	$ 29.78	$ 14.72	$ 12.97
Risk-free discount rate, minimum	1.72%	2.32%	1.67%
Risk-free discount rate, maximum	2.29%	2.84%	1.85%
Volatility	43.00%	45.00%	47.00%
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life	4 years 2 months 12 days	4 years 1 month 6 days	3 years 7 months 6 days
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected life	4 years 4 months 24 days	4 years 2 months 12 days	4 years 2 months 12 days

Stock Options And Restricted Stock Awards (Summary of Status of Unvested Restricted Stock Awards Outstanding) (Details) - Restricted Stock [Member] shares in Thousands	12 Months Ended
	Dec. 31, 2019 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested restricted stock awards at beginning of period \| shares	149
Awarded \| shares	69
Vested \| shares	(66)
Forfeited \| shares	(3)
Unvested restricted stock awards at end of period \| shares	149
Weighted Average Grant Date Fair Value beginning of period \| $ / shares	$ 36.10
Weighted Average Grant Date Fair Value, Awarded \| $ / shares	68.91
Weighted Average Grant Date Fair Value, Vested \| $ / shares	35.58
Weighted Average Grant Date Fair Value, Forfeited \| $ / shares	53.54
Weighted Average Grant Date Fair Value end of period \| $ / shares	$ 51.10

Employee Benefit Plans (Narrative) (Details) - 401(k) Retirement Plan [Member] - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Defined Contribution Plan Disclosure [Line Items]
Matching percentage for retirement plan	6.00%	6.00%	6.00%
Company matching contribution amount	$ 200,000	$ 300,000	$ 44,000

Commitments and Contingencies (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2019 USD ($) Facility	Nov. 05, 2018 Time
Commitments And Contingencies [Line Items]
Settlement expense in discontinued operation \| $	$ 0.6
Amended and restated employment agreement date	Nov. 05, 2018
Senior Management [Member] \| Maximum [Member]
Commitments And Contingencies [Line Items]
Employment agreement term	4 years
Chief Executive Officer [Member]
Commitments And Contingencies [Line Items]
Number of annual compensation times on termination of employment		2
Amended Number of Annual Compensation Times on Termination of Employment		3
Executive Officer [Member]
Commitments And Contingencies [Line Items]
Number of annual compensation times on termination of employment		1
Amended Number of Annual Compensation Times on Termination of Employment		2
Illinois [Member]
Commitments And Contingencies [Line Items]
Number of senior living facilities \| Facility	3

Segment Information (Narrative) (Details)	12 Months Ended
Segment Information (Narrative) (Details)	Dec. 31, 2019 segment
Segment Reporting [Abstract]
Number of business segments	3

Segment Information (Summary of Segment Information) (Details) - USD ($) $ in Thousands	3 Months Ended									12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 30, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Segment Reporting Information [Line Items]
Net service revenues	$ 192,376	$ 168,993	$ 148,915	$ 138,507	$ 139,288	$ 139,288	$ 137,341	$ 130,892	$ 109,126	$ 648,791	$ 516,647	$ 425,994
Cost of services revenues										469,553	379,843	310,119
Gross profit	57,542	45,176	39,693	36,827	37,429	37,429	36,415	35,377	27,583	179,238	136,804	115,875
General and administrative expenses										133,569	105,025	76,902
Provision for doubtful accounts										343	272	9,524
Operating income from continuing operations	$ 14,530	$ 7,335	$ 7,391	$ 5,496	$ 6,428	$ 6,428	$ 5,613	$ 6,547	$ 4,239	34,752	22,827	25,253
Other general and administrative expenses										61,421	55,282	41,247
Depreciation and amortization										10,574	8,642	6,663
Loss (gain) on sale of assets										0	38	(2,467)
Interest income										(1,523)	(2,592)	(66)
Interest expense										3,105	5,016	4,472
Other income										0	0	(217)
Income from continuing operations before income taxes										33,170	20,403	21,064
Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses										72,148	49,743	35,655
Operating income from continuing operations										106,747	86,789	70,696
Personal Care [Member]
Segment Reporting Information [Line Items]
Net service revenues										580,728	490,941	425,994
Cost of services revenues										432,413	365,264	310,119
Gross profit										148,315	125,677	115,875
Provision for doubtful accounts										242	265	9,524
Personal Care [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses										56,645	44,463	35,655
Operating income from continuing operations										91,428	80,949	70,696
Hospice [Member]
Segment Reporting Information [Line Items]
Net service revenues										53,601	18,850	0
Cost of services revenues										27,203	10,010	0
Gross profit										26,398	8,840	0
Provision for doubtful accounts										95	5	0
Hospice [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses										12,304	3,737	0
Operating income from continuing operations										13,999	5,098	0
Home Health [Member]
Segment Reporting Information [Line Items]
Net service revenues										14,462	6,856	0
Cost of services revenues										9,937	4,569	0
Gross profit										4,525	2,287	0
Provision for doubtful accounts										6	2	0
Home Health [Member] \| Operating Segments [Member]
Segment Reporting Information [Line Items]
General and administrative expenses										3,199	1,543	0
Operating income from continuing operations										$ 1,320	$ 742	$ 0

Significant Payors (Revenue by Payor Type) (Details) - USD ($) $ in Thousands	3 Months Ended									12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 30, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Net service revenues	$ 192,376	$ 168,993	$ 148,915	$ 138,507	$ 139,288	$ 139,288	$ 137,341	$ 130,892	$ 109,126	$ 648,791	$ 516,647	$ 425,994
Personal Care [Member]
Net service revenues										580,728	490,941	425,994
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues										$ 580,728	$ 490,941	$ 425,994
Concentration risk, percentage										100.00%	100.00%	100.00%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| State, Local And Other Governmental Programs [Member]
Net service revenues										$ 303,479	$ 285,973	$ 273,525
Concentration risk, percentage										52.20%	58.20%	64.20%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues										$ 239,559	$ 173,391	$ 140,993
Concentration risk, percentage										41.30%	35.30%	33.10%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Private Pay [Member]
Net service revenues										$ 21,765	$ 20,003	$ 8,739
Concentration risk, percentage										3.70%	4.10%	2.10%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Commercial Insurance [Member]
Net service revenues										$ 9,204	$ 6,173	$ 2,737
Concentration risk, percentage										1.60%	1.30%	0.60%
Personal Care [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues										$ 6,721	$ 5,401
Concentration risk, percentage										1.20%	1.10%
Hospice [Member]
Net service revenues										$ 53,601	$ 18,850	$ 0
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues										$ 53,601	$ 18,850
Concentration risk, percentage										100.00%	100.00%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Medicare [Member]
Net service revenues										$ 49,649	$ 17,652
Concentration risk, percentage										92.60%	93.60%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues										$ 2,768	$ 1,047
Concentration risk, percentage										5.20%	5.60%
Hospice [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues										$ 1,184	$ 151
Concentration risk, percentage										2.20%	0.80%
Home Health [Member]
Net service revenues										$ 14,462	$ 6,856	$ 0
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member]
Net service revenues										$ 14,462	$ 6,856
Concentration risk, percentage										100.00%	100.00%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Medicare [Member]
Net service revenues										$ 11,218	$ 6,034
Concentration risk, percentage										77.60%	88.00%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Managed Care Organizations [Member]
Net service revenues										$ 2,942	$ 752
Concentration risk, percentage										20.30%	11.00%
Home Health [Member] \| Revenues [Member] \| Customer Concentration Risk [Member] \| Other [Member]
Net service revenues										$ 302	$ 70
Concentration risk, percentage										2.10%	1.00%

Significant Payors (Revenue by Geographic Location) (Details) - USD ($) $ in Thousands	3 Months Ended									12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 30, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Net service revenues	$ 192,376	$ 168,993	$ 148,915	$ 138,507	$ 139,288	$ 139,288	$ 137,341	$ 130,892	$ 109,126	$ 648,791	$ 516,647	$ 425,994
Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Concentration risk, percentage										38.20%	45.00%	52.60%
Personal Care [Member]
Net service revenues										$ 580,728	$ 490,941	$ 425,994
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues										$ 580,728	$ 490,941	$ 425,994
Concentration risk, percentage										100.00%	100.00%	100.00%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Net service revenues										$ 247,524	$ 232,518	$ 224,257
Concentration risk, percentage										42.60%	47.30%	52.60%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New York [Member]
Net service revenues										$ 108,403	$ 65,117	$ 58,360
Concentration risk, percentage										18.70%	13.30%	13.70%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues										$ 75,666	$ 58,914	$ 37,588
Concentration risk, percentage										13.00%	12.00%	8.80%
Personal Care [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| All Other States [Member]
Net service revenues										$ 149,135	$ 134,392	$ 105,789
Concentration risk, percentage										25.70%	27.40%	24.90%
Hospice [Member]
Net service revenues										$ 53,601	$ 18,850	$ 0
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues										$ 53,601	$ 18,850
Concentration risk, percentage										100.00%	100.00%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues										$ 38,790	$ 18,850
Concentration risk, percentage										72.40%	100.00%
Hospice [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| All Other States [Member]
Net service revenues										$ 14,811
Concentration risk, percentage										27.60%
Home Health [Member]
Net service revenues										$ 14,462	$ 6,856	$ 0
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member]
Net service revenues										$ 14,462	$ 6,856
Concentration risk, percentage										100.00%	100.00%
Home Health [Member] \| Revenues [Member] \| Geographic Concentration Risk [Member] \| New Mexico [Member]
Net service revenues										$ 14,462	$ 6,856
Concentration risk, percentage										100.00%	100.00%

Significant Payors (Narrative) (Details)	12 Months Ended
Significant Payors (Narrative) (Details)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Revenues [Member] \| Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	25.30%	31.70%	36.50%
Revenues [Member] \| Geographic Concentration Risk [Member] \| Illinois [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	38.20%	45.00%	52.60%
Accounts Receivable [Member] \| Illinois Department On Aging [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	25.10%	23.10%

Unaudited Summarized Quarterly Financial Information (Schedule of Quarterly Results of Operations) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended									12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 30, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]
Net service revenues	$ 192,376	$ 168,993	$ 148,915	$ 138,507	$ 139,288	$ 139,288	$ 137,341	$ 130,892	$ 109,126	$ 648,791	$ 516,647	$ 425,994
Gross profit	57,542	45,176	39,693	36,827	37,429	37,429	36,415	35,377	27,583	179,238	136,804	115,875
Operating income from continuing operations	14,530	7,335	7,391	5,496	6,428	6,428	5,613	6,547	4,239	34,752	22,827	25,253
Net income from continuing operations	10,737	5,486	5,292	4,296	4,266	4,266	3,358	4,052	4,631	25,811	16,307	11,806
(Loss) earnings from discontinued operations		(574)			126					(574)	126	147
Net income	$ 10,737	$ 4,912	$ 5,292	$ 4,296	$ 4,392	$ 4,392	$ 3,358	$ 4,052	$ 4,631	$ 25,237	$ 16,433	$ 11,953
Average shares outstanding:
Basic	15,435	13,766	13,044	12,995	12,964		12,179	11,533	11,502	13,816	12,049	11,470
Diluted	15,881	14,203	13,433	13,381	13,381		12,569	11,838	11,696	14,248	12,383	11,623
Basic
Continuing operations	$ 0.70	$ 0.40	$ 0.41	$ 0.33	$ 0.33		$ 0.28	$ 0.35	$ 0.40	$ 1.87	$ 1.35	$ 1.03
Discontinued operations		(0.04)			0.01					(0.04)	0.01	0.01
Basic income per share	0.70	0.36	0.41	0.33	0.34	$ 0.34	0.28	0.35	0.40	1.83	1.36	1.04
Diluted net income per share
Continuing operations	0.68	0.39	0.39	0.32	0.32		0.27	0.34	0.40	1.81	1.32	1.02
Discontinued operations		(0.04)			0.01					(0.04)	0.01	0.01
Diluted income per share	$ 0.68	$ 0.35	$ 0.39	$ 0.32	$ 0.33	$ 0.33	$ 0.27	$ 0.34	$ 0.40	$ 1.77	$ 1.33	$ 1.03

Unaudited Summarized Quarterly Financial Information (Schecule of Effects of Corrections of Errors on Unaudited Quarterly Results of Operations) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended									12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 30, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Quarterly Financial Information Disclosure [Line Items]
Net service revenues	$ 192,376	$ 168,993	$ 148,915	$ 138,507	$ 139,288	$ 139,288	$ 137,341	$ 130,892	$ 109,126	$ 648,791	$ 516,647	$ 425,994
Gross profit	57,542	45,176	39,693	36,827	37,429	37,429	36,415	35,377	27,583	179,238	136,804	115,875
Operating income from continuing operations	14,530	7,335	7,391	5,496	6,428	6,428	5,613	6,547	4,239	34,752	22,827	25,253
Net income from continuing operations	10,737	5,486	5,292	4,296	4,266	4,266	3,358	4,052	4,631	25,811	16,307	11,806
Net income	$ 10,737	$ 4,912	$ 5,292	$ 4,296	$ 4,392	$ 4,392	$ 3,358	$ 4,052	$ 4,631	$ 25,237	$ 16,433	$ 11,953
Basic	$ 0.70	$ 0.36	$ 0.41	$ 0.33	$ 0.34	$ 0.34	$ 0.28	$ 0.35	$ 0.40	$ 1.83	$ 1.36	$ 1.04
Diluted	$ 0.68	$ 0.35	$ 0.39	$ 0.32	$ 0.33	$ 0.33	$ 0.27	$ 0.34	$ 0.40	$ 1.77	$ 1.33	$ 1.03
As Previously Reported [Member]
Quarterly Financial Information Disclosure [Line Items]
Net service revenues		$ 169,803	$ 149,692	$ 139,254		$ 139,669	$ 137,716	$ 131,258	$ 109,476		$ 518,119	$ 425,994
Gross profit		45,986	40,470	37,574		37,810	36,790	35,743	27,933		138,276	115,875
Operating income from continuing operations		7,280	7,713	6,243		6,809	5,988	6,913	4,589		24,299	26,368
Net income from continuing operations		5,441	5,518	4,862		4,542	3,631	4,318	4,886		17,377	13,534
Net income		$ 4,867	$ 5,518	$ 4,862		$ 4,668	$ 3,631	$ 4,318	$ 4,886		$ 17,503	$ 13,681
Basic		$ 0.36	$ 0.42	$ 0.37		$ 0.36	$ 0.29	$ 0.37	$ 0.42		$ 1.45	$ 1.19
Diluted		$ 0.34	$ 0.41	$ 0.36		$ 0.35	$ 0.28	$ 0.36	$ 0.42		$ 1.41	$ 1.17
Revision [Member]
Quarterly Financial Information Disclosure [Line Items]
Net service revenues		$ (810)	$ (777)	$ (747)		$ (381)	$ (375)	$ (366)	$ (350)		$ (1,472)
Gross profit		(810)	(777)	(747)		(381)	(375)	(366)	(350)		(1,472)
Operating income from continuing operations		55	(322)	(747)		(381)	(375)	(366)	(350)		(1,472)	$ (1,115)
Net income from continuing operations		45	(226)	(566)		(276)	(273)	(266)	(255)		(1,070)	(1,728)
Net income		$ 45	$ (226)	$ (566)		$ (276)	$ (273)	$ (266)	$ (255)		$ (1,070)	$ (1,728)
Basic			$ (0.01)	$ (0.04)		$ (0.02)	$ (0.01)	$ (0.02)	$ (0.02)		$ (0.09)	$ (0.15)
Diluted		$ 0.01	$ (0.02)	$ (0.04)		$ (0.02)	$ (0.01)	$ (0.02)	$ (0.02)		$ (0.08)	$ (0.14)

Subsequent Events (Narrative) (Details) $ in Thousands			1 Months Ended	12 Months Ended
Subsequent Events (Narrative) (Details) $ in Thousands	Jul. 01, 2020 USD ($)	Feb. 17, 2020 USD ($) ft²	Apr. 30, 2020 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Dec. 31, 2017 USD ($)
Subsequent Event [Line Items]
Total purchase price for business acquisition				$ 184,076	$ 62,440	$ 24,354
Subsequent Event [Member] \| A Plus Health Care, Inc [Member]
Subsequent Event [Line Items]
Total purchase price for business acquisition	$ 12,200
Subsequent Event [Member] \| Relief Fund {Member]
Subsequent Event [Line Items]
Aggregate principal amount of grants received under CARES Act			$ 6,900
Frisco Support Center [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Lease agreement term		11 years
Area of space before expand \| ft²		31,000
Area of space after expand \| ft²		75,000
Increase in the operating lease asset, net		$ 13,000
Increase in operating lease liability		$ 17,000

Valuation And Qualifying Accounts (Details) - Allowance For Doubtful Accounts [Member] - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2017

Valuation and Qualifying Accounts Disclosure [Line Items]

Balance at beginning of period

$ 945

$ 18,749

$ 14,460

Additions/charges

343

272

9,524

Deductions

^[1]

326

18,076

5,235

Balance at end of period

$ 962

$ 945

$ 18,749

[1]	Write-offs, net of recoveries

Valuation And Qualifying Accounts (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended									12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 30, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Valuation and Qualifying Accounts Disclosure [Line Items]
Revenues	$ 192,376	$ 168,993	$ 148,915	$ 138,507	$ 139,288	$ 139,288	$ 137,341	$ 130,892	$ 109,126	$ 648,791	$ 516,647	$ 425,994
Allowance For Doubtful Accounts [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Increase in allowance for doubtful accounts											300	$ 8,200
Deductions for allowance for doubtful accounts											7,900
Accounting Standards Update 2014-09 [Member]
Valuation and Qualifying Accounts Disclosure [Line Items]
Revenues											$ (11,000)